The role of Depo Provera in the Indonesian family planning program by Margono, Sugeng
THE ROLE OF DEPO PROVERA
IN
THE INDONESIAN FAMILY PLANNING PROGRAM
By
SUGENG MARGONO
A thesis submitted for the degree of 
Masters of Arts
at the Australian National University.
December 1985
1'8 hart \\
DECLARATION
Except where otherwise indicated 
this thesis is my own work.
A / '
SUGENG /MARGONO/ /December 1985
iii
ACKNOWLEDGEMENTS
I wish to express my appreciation to many individuals and 
institutions especially the National Family Planning Coordinating Eoard 
of Indonesia, the Development Studies Centre of Australian National
University, and the United Nation Fund for Population Activities who 
made possible both the opportunity to study in Australia as well as the 
completion of this thesis.
Many thanks go to all who provided the invaluable assistance, 
guidance and support, especially to Mrs. Christine McMurray, Mrs. Lulu 
Bost, Mr. Rodney Cole and Mrs. Carol Mehkek.
My special gratitude is to my family (Mud ji Margono, Asherrita 
Margono, Brian Margono and my beloved Father and Mother in Jl. Padang
and Jepara), for their constant source of love, patience, understanding 
and moral support while I was away from home.
My intellectual dept is to Dr Terence H. Hull, my supervisor.
My deepest gratitude to my God who always meets all my needs.
ABSTRACT
The purposes of this study are to examine the acceptability of Depo
Provera (DP) as a possible alternative contraceptive in Indonesia; to 
investigate the side effects commonly experienced by Indonesian women
and to examine how they tolerate these side effects.
The analysis is based on three sources: the results of a field
work case study in Jakarta, Bandung and Yogyakarta of 1985; the 
contraceptive continuation module of the family planning modular survey
of 1982; and family planning service statistics reports.
Since the decision of the US Pood and Drug Administration (FDA) not 
to grant approval for the use of DP as a contraceptive in the United 
States, in 1978, debates and controversy have been going on up to the 
time of writing. This decision made thousands of women afraid of getting 
cancer or fearful that DP will impair their fertility. Eecause of this 
controversy, the usage of DP as a contraceptive is being carefully 
monitored by IPPF and V/HC through multinational comparative studies in 
15 developed and developing countries around the world. Evidence is 
mounting from world wide experience, that DP is a satisfactory 
contraceptive with several advantages and some disadvantages but no more 
serious side effects than those found in oral contraceptives.
The field study demonstrated the acceptability of DP among 
respondents. The greatest obstacle to use was the cost of the drug. 
Most respondents postponed their follow-up injections for that reason, 
but still they did not drop-out. They used other methods to avoid 
pregnancy during their period without DP. These respondents would gladly 
have another injection when they had money to pay for the service (and
the drug). The selection of DP by respondents was mostly through self 
evaluation, comparasion and consideration (most of the respondents have
used one or another methods in the past), and the decision appeared to
Vbe a solid decision, not just "follow the leader". The respondents also 
indicated that they could tolerate the side effects. It appeared that 
they easily managed menstrual disturbances, while most respondents were 
happy about the most common side effect, amenorrhoea, because it allowed 
them to avoid the "monthly trouble" caused by menstruation in disrupting 
their daily religious activities. They also benefited through avoiding 
anaemia, and some respondents preferred DP for post-partum use, because 
it does not suppress breast milk production.
In sumary, the study found DP to be an acceptable form of 
contraception. It is perceived by Indonesian women and practitioners as 
a safe and reliable alternative to existing birth control techniques.
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1CHAPTER 1
THE BACKGROUND OF THE STUDY
1.1 Introduction
At the beginning of the Indonesian Family Planning Program (1970), 
the majority of new acceptors, 55$, used intrauterine devices (lUDs) 7$ 
of new acceptors used contraceptive pills and the rest, 18$, were using 
condoms. As the availability and distribution of pills through the 
Community Based Program improved, especially at the village level 
through Village Contraception Distribution Centers (VCDCs), pills became 
the most popular choice in the country. In 1979/1980, the first year of 
the Second Five Year Plan (Pelita II), new acceptors totalled 2,229,791* 
The main choice was pills 69*5$, followed by the IUD, 17.8$, and condoms 
7.6$ [NFPCB, 1985: 163].
It is generally accepted that the use of contraceptive pills 
requires high motivation, self discipline and regularity to gain full 
protection from pregnancy. In Indonesia, as in many developing 
countries, failure rates are substantial. For example, a 1976 survey in 
the Philippines reported 8 pregnancies per 100 women years during the 
first year of pill use, and 9*2 pregnancies per 100 during the second 
year [haing and Alcantara, 1980: 119]* In East Java, from 14 to 21 per 
cent of users become pregnant during the first year of pill use 
[Sullivan et al., 1976: 190]. A major problem is irregular pill taking. 
Most Indonesian women, especially in the rural areas, are uneducated. 
They are not accustomed to taking pills to a regular schedule and may 
not understand that skipping a pill or two can reduce the contraceptive 
effect. Similarly, rural and uneducated condom users may have difficulty 
becoming accustomed to "a new habit" when having intercourse. For these 
reasons since 1976 the Indonesian Family Planning Program has made 
serious studies of "injectable" contraception [NFPCB, 1976: 1l].
2Following the good results of clinical trials, injectable contraception, 
especially Depo Provera (DP), has been offered by the Indonesian Family 
Planning Program since 1982 [NFPCB,1985: 203]«
1.2 Objectives of the Study
The objectives of this study are to examine the acceptability of DP 
as a possible alternative contraceptive in Indonesia; to evaluate the 
effectiveness of this contraception; and finally, to examine the side 
effects commonly suffered by Indonesian women and how they tolerate DP.
DP has been selected for study for several reasons:
Firstly, although "the method of choice" in Indonesia is pills, as 
mentioned above, pills have some weaknesses for rural, uneducated women. 
This study tries to show that DP has some advantages and is one of the 
possible alternative methods for fertility regulation which could 
replace the pill, or at least could be used as a back up method in the 
Program.
Secondly, DP is simple to administer, (one shot for three months), 
highly effective and reversible. The way of administering this drug has 
advantages for the new candidate, who has previously refused to use any 
contraception because it avoids genital exposure to medical personnel, 
the chore of swallowing pills every night, and the need to become 
accustomed to "new habits", especially before intercourse.
Abortion is prohibited by Indonesian law and sterilization is not 
available in the Program as it is still on clinical trial [Widjanarko, 
1984: 69]. Furthermore, injections have long been popular as medical 
treatment in Indonesia, so the injectable contraceptive should gain 
popularity very soon, and win important support for the Program.
Thirdly, as in other developing countries, most babies especially 
in rural areas, depend upon their mother's milk. The contraceptive 
method now popular in Indonesia, the pill, unfortunately suppresses 
breast milk. On the contrary, DP prolongs the duration of lactation, and 
adds to the quantity of breast milk or at least does not suppress 
lactation [Agoestina, 1976: 1-7]. The quality of breast milk is not 
altered; the growth and wieght gain of the infant is not impaired
3[ V o r h e r r ,  1973: 1011; Koetsawang,  e t  a l . ,  1982: 321-331]* F u r th e r m o r e ,  
most I n d o n e s i a n  women have t o l e r a t e d  w e l l  the  s i d e  e f f e c t s  o f  DP, such 
as  am enor rhoea ,  i r r e g u l a r  m enses ,  w e ig h t  g a i n ,  and l o s t  o f  h a i r .
Java  and B a l i  ( s e e  f i g u r e  1-1 ) were s e l e c t e d  as  the  a r e a s  f o r  
c o n s i d e r a t i o n  b e c a u s e ,  F i r s t l y ,  s i n c e  i t s  i n c e p t i o n  i n  1970 t h e  N a t i o n a l  
Family  P l a n n in g  Program (NFPCB) has  c o n c e n t r a t e d  on th e  d e n s e l y  
p o p u l a t e d  i s l a n d s  o f  Java  and B a l i .  These two i s l a n d s  g e t  f i r s t  
p r i o r i t y  due to  t h e i r  u r g e n t  p o p u l a t i o n  s i t u a t i o n  [P o e d jo  R a h a r d jo ,  
1984: 3]* S e c o n d ly ,  Java  and B a l i  c o n s i s t  o f  6 p r o v i n c e s ,  c o n s i d e r e d  a s  
l e a d i n g  a r e a s  i n  I n d o n e s i a ,  which make t h e  i m p o r t a n t  d e c i s i o n s  i n  a lm o s t  
a l l  I n d o n e s i a n  deve lopmen t  programmes. In  t h e  I n d o n e s i a n  Family  P l a n n i n g  
Program t h e s e  two i s l a n d s  a r e  viewed as  " w i la ya h  p enen tu"  ( t h e  a r e a s  
t h a t  ho ld  the  f i n a l  d e c i s i o n s )  f o r  the  s u c c e s s  o r  f a i l u r e  o f  t h e  
Program. This  i s  be c ause  64$ o f  t h e  I n d o n e s i a n  p o p u l a t i o n  l i v e  i n  Java  
and B a l i  [BPS, 1983: 2 ] ,  and 73$ o f  f a m i ly  p l a n n i n g  a c c e p t o r s  come from 
t h e s e  i s l a n d s  [Poed jo  R a h a r d jo ,  1984: 20 ] .
1 .3  The I n d o n e s i a n  Fam ily  P l a n n i n g  Program 
1.3*1 The P o p u l a t i o n
As i n  o t h e r  d e v e l o p i n g  c o u n t r i e s ,  I n d o n e s i a  i s  f a c i n g  the  problem 
o f  p o p u l a t i o n  e x p l o s i o n .  In  the  p o p u l a t i o n  c e n s u s e s  o f  1961, 1971 and 
1980, I n d o n e s i a ' s  p o p u l a t i o n  was r e s p e c t i v e l y  97 m i l l i o n ,  119*2 m i l l i o n  
and 147 .5  m i l l i o n  [NFPCB, 1982: i x ] ,  and ran k s  the  f i f t h  l a r g e s t  
p o p u l a t i o n  i n  t h e  wor ld  a f t e r  China ,  I n d i a ,  USSR and USA.
A l a r g e  p o p u l a t i o n  s i z e  o f  a b o u t  147.5 m i l l i o n  i n  1980 coup led  w i t h  
a p o p u l a t i o n  growth r a t e  o f  2 . 3  p e r  c e n t  be tween  1971 and 1980 [BPS, 
1983: 7]  adds more t han  the  p r e s e n t  p o p u l a t i o n  o f  S in g a p o re  each y e a r  
to  I n d o n e s i a .  I f  the  t r e n d  c o n t i n u e s ,  and i t  i s  u n l i k e l y  to  s t o p  f o r  a t  
l e a s t  a n o t h e r  g e n e r a t i o n ,  i t  i s  p o s s i b l e  t h a t  I n d o n e s i a  cou ld  move from 
No 5 to  No 3 i n  r a n k i n g  i n  the  w o r ld ,  be c ause  USSR and USA have growth 
r a t e s  f a r  below 2 p e r  c e n t  p e r  y e a r  [Samekto ,  1984: l ] .
A l though  the  land  a r e a  o f  I n d o n e s i a  i s  s t i l l  q u i t e  v a s t ,  the  
m a l d i s t r i b u t i o n  o f  I n d o n e s i a ' s  l a r g e  p o p u l a t i o n  i s  a cause  f o r  c o n c e r n .  
Over 60 p e r  c e n t  o f  t h e  p o p u l a t i o n  l i v e  on th e  i s l a n d s  o f  Java  and
4Madura, which comprise only about seven per cent of the total land area. 
As a result, Java has a high density rate of 667 people per square 
kilometer, whule out side Java and Bali, the rate is only about 46 
people pr square kilometer [NFPCB, 1981: 3]*
In addition, a high porpotion (45 per cent) of the population are 
under 15 years of age and added to the 2.5 per cent from the older age 
groups (above 64 years old) make up a high proportion of those who are 
economically unproductive.
While movement from a lower to a higher social status (vertical 
mobility) is rare and movement from one area to another areas has been 
rapid, thus, giving rise to acute problems of urbanization [Samekto, 
1984: 1 ]. The population of Indonesia could also be discribed in terms 
of qualitative characteristics, as having a low of general education, 
low health and nutrional standards, low income per capita, a high 
unemployment rate and still being an agricultural society [NFPCB, 1981: 
4]. Whit those attributes in view, the Government and the public became 
aware of the necessity of implementing an aggressive Family Planning 
Program, which has been in operation officially since 1970.
1.3*2 The Development of the Program
Small scale efforts in family planning in Indonesia, which provided 
the ground work for the National Family Planning Program, began several 
decades ago. The Indonesian Planned Parenthood Association (IPPA) began 
propagating family planning and .offered family planning services in the 
1950s. The "old order" top leadership did not give much thought to 
family planning [Hull, et al., 1967: 3; Ryder, 1971: 128]. The situation 
changed drastically when the "new order" leadership took office in 1966. 
President Suharto was one of the national leaders who signed the 
Declaration on Population. The government established the National 
Family Planning Institute (LKBN) in 1968, which had a semi-governmental 
status. Two years later in 1970, family planning gained a more solid 
status as a fully government sponsored National Program with the newly 
established National Family Planning Coordinating Board (NFPCB) 
functioning as national coordinator [Yudono, 1979: 8; Sumbung, et al., 
1981: 3-4].
5As a first step the program was implemented on Java and Bali, the 
two most densely populated islands, which carried the majority of 
Indonesia's population. The program at that time was aimed at recruiting 
family planning acceptors through provision of family planning 
information/motivation and contraceptive services. Considering the good 
results achieved in Java-Bali during the first Five Year Development 
Plan (FYDP) 1970-1974, in 1974/1975 the NFPCB started to expand program 
implementation to include ten additional provinces outside Java-Bali. 
The program gained a strong foothold as an integral part of the total 
national development program. The target expanded not only in terms of 
number of acceptors but also in terms of the efficiency of the 
contraceptives being used i e. the quality of acdceptance. Follow up 
motivation and counselling were provided to reinforce and improve the 
quality of acceptance, so that a significant impact on the overall 
development effort could reasonably be expected. Considering the 
satisfactory results in Java-Bali and in the Outer Island provinces, the 
goverment decided to further expand program implementation, so that all 
27 provinces were covered in the third FYDP [Yudono, 1979: 2-3;
Mubramsyah and Slamet, 1980: 3-4].
1.3*3 The Objectives of the Program
The National Family Planning Program has a quantitative as well as 
qualitative objective. Originally its quantitative aim was stated as a 
50 per cent fertility decline of the level in 1971 to be attained in the 
year 2000. Setting this target was intended to inject a sense of purpose 
and time, and some competitive spirit among program administrators and 
workers in the field, thereby intensifying program implementation. Based 
on the results and progress of the program, the target has been reset to 
attainment of 50 per cent fertility decline by the year 1990. Obviously, 
this ten year acceleration poses a tremendous challenge to the Program. 
The qualitative goal of the Program is institutionalization of the 
"Happy and Prosperous Small Family" norms in the community at large. 
With families having only a few children, it was thought these would be 
a greater likelihood that live will get better, happier and more
6prosperous, socially as well as economically. It is in the light of this 
normative goal that "beyond family planning" activities are being 
implemented in conjunction with family planning motivation and 
contraceptive service activities.
1.3*4 The Implementation Strategy
With 27 provinces in Indonesia, all geographically and culturally 
distinct, the NFPCB had to set priorities for implementing its program.
First, geographic strategy was set, concentrated primarily in the 
islands of Java and Bali, followed by ten other Provinces, Outer islands 
I and then Outer islands II [Yudono, 1973; Mubramsyah and Slamet, 1980:
1 — 10], as shown in Figures 1-1 and 1-2.
The second strategy was the clinic based service delivery approach, 
which could utilize the existing national clinical facilities of the 
Ministry of Health, the Armed Forces, and the Private sector. The 
integrated service delivery approach was chosen as the most efficient 
approach for initial expansion of the program since it required little 
infrastructural development, since it used existing facilities and 
personnel.
The third strategy was the community based service delivery 
approach, for more effectiveness in improving services. These 
village-based units consist of fieldworkers and "Village Contraceptive 
Distribution Centers" (VCDCs), where follow up pills and condoms are 
distributed.
Because it was found that program achievements varied greatly from 
place to place or from province to province. Program managers decided 
to categorize the various program areas into several achievement 
oriented groupings based on the percentage of current (active) users 
from family planning eligible couples. These were called segmentation 
areas and were defined as: Phase I areas: where the percentage of
current users was less than 15* Program efforts in these areas stressed 
the extension of services. Phase II areas: where the percentage of
current users was between 15-35* In this places it was assumed that 
social and community dynamics in support of family planning program had
7already emerged. In these areas attention is given to sustainance of 
achievements. Phase III areas: where the percentage of current users was 
beyond 55* Dynamic social and community leadership in organized family 
planning works was becoming more solid and FP activities were better 
integrated with efforts in other fields. Program officials were 
instructed to pay attention to the institutionalization of the small 
family norm.
Phase IV areas: where the percentage of current users was 55-75* 
In these areas, social and community dynamics in support of FP were 
spread fairly evenly over the sub-villages. Family planning groups which 
formerly laid emphasis on social activities were beginning to involve 
themselves in economic activities.
Phase V areas: areas where the percentage of current users was 
beyond 75* At this very advanced program stage, performance of economic 
activities by community groups was assumed to be widespread. There was 
also a tendency for many couples in these areas to become self 
sufficient in fulfilling their contraceptive needs.
In addition to these two types segmentation, the total program was 
divided into different program phases. The operational scheme also 
involved "time priority" or "time segmentation". This meant the 
scheduling of work by periods to ensure timely attainment of the annual 
target. About 40-60 per cent of the total new acceptors target was to be 
completed during the First Periods which extended from April through to 
August each year, (the fiscal year is April 1 to March 51 next year). 
The remaining portion, 60-100 .per cent of the target, was to be 
completed by the end of the Second Periods (September - December). The 
three closing months of the fiscal year (January - March) were basically 
reserved for consolidating these new acceptors. In other words, this 
remaining time was meant for quality control.
The fifth priority was called "target segmentation". This working 
concept was developed during the 1982 Rakernas (Annual National Family 
Planning Working Conference), and comprised the Panca Karya Strategy 
(Five Points Strategy) and the Catur Bhava Utama (Four Key Support 
Pillars Strategy). The five points in the Panca Karya Strategy were as
follows:
81. Encourage and help couples with wives aged below 30 or with 
less than three children, to have a total of no more than two 
children.
2. Encourage and help fertile couples with wives aged 30 or over, 
or with three or more children, not to have any more children.
3. Guide the young generation towards a solid understanding of the 
"Happy and Prosperous Small Family" norm as the appropriate
and responsible way of life, and help them get more actively 
involved in social activities.
4. Intensify physical institutionalization of the family planning 
dissemination process, so that collective performance of family 
planning activities by community groups was increasingly 
becoming an integral part of their day to day activity.
5« Strengthen the mental and spiritual aspects of the family 
planning institutionalization, mainly the psychological 
aspects, so that family planning acceptors enjoy a sense 
of mental confidence and emotional security.
Catur Bhava Utama mentioned four key program support pillars: man, 
money, facilities and method [NFPCB, 1984: 10-14].
The sixth, and last, priority was called "Total mobilization". 
This was the operational priority or " recruitment of new acceptors by 
total actions", which mobilize all relevant social as well as material 
resources into a concerted family planning compaign. It was applied for 
the first time in West Java province with the name "Safary Spiral" 
(safary, to boost IUD acceptance). The purpose of the family planning 
Safary campaign was mainly to add impetus to this rather slow growing 
program, to enable the West Java program to catch up with it colleagues 
in other Java and Bali provinces. This operational pattern is now being 
applied widely in many parts of the country and is popularly known as 
"SAFARY SMILE".
Regionally, the NFPCB has offices in all 27 provinces in Indonesia 
and its administrative infrastructure now extends to all regencies in 
the country through its regency level offices. At the Sub-Regency 
administrative level, family planning services are administratively 
integrated with other sectoral programs. At the village level the NFPCB
9employs f i e l d  w o rk e rs  who a r e  r e s p o n s i b l e  f o r  s u p e r v i s i n g  a l l  i n t e g r a t e d  
s e r v i c e  d e l i v e r y  i n  t h e  v i l l a g e s .  The v i l l a g e  i n f r a s t r u c t u r e  c o n s i s t s  
o f  v i l l a g e  c o n t r a c e p t i v e  d i s t r i b u t i o n  c e n t e r s  s t a f f e d  by v o l u n t e e r s ,  
which  a r e  o p e r a t e d  by 180,000  community a c c e p t o r s  g roups  [NFPCB, 1981: 
2 ].
1.3*5  The Main Components o f  t h e  I n d o n e s i a n  Fam ily  P l a n n i n g  Program.
The f a m i ly  p l a n n i n g  program i s  c a r r i e d  ou t  by p r i v a t e  as  w e l l  a s  
government  u n i t s .  Thus,  as  a c o o r d i n a t i n g  body,  the  NFPCB m o b i l i z e s  
a v a i l a b l e  manpower from o t h e r  i n s t i t u t i o n s  f o r  the  b e n e f i t  o f  t h e  
program. For i n s t a n c e ,  m e d i c a l  and p a r a m e d i c a l  p e r s o n n e l ,  and c l i n i c a l  
f a c i l i t i e s  and equ ipment  from t h e  Depar tm ent  o f  H e a l th  and Armed F o r c e s  
Im plementing  U n i t s  a r e  a l l  u t i l i z e d .  Also ,  i n f o r m a t i o n  o f f i c i a l s ,  
i n f o r m a t i o n  mobil e  u n i t s  and r a d i o  b r o a d c a s t i n g ,  unde r  t h e  Departm ent  o f  
I n f o r m a t i o n ,  a r e  u s e d .  As the  Depar tm ent  o f  H e a l t h  and Departm ent  o f  
I n f o r m a t i o n ,  t h e  Government  a p p a r a t u s  unde r  t h e  Departm ent  o f  Home 
A f f a i r s  i s  used as  a fu n d am e n ta l  key to  the  s u c c e s s  o f  t h e  Program. 
O th e r  im p lem en t ing  u n i t s  i n  c l o s e  c o o p e r a t i o n  a r e  t h e  Depar tm ent  o f  
E d u c a t i o n  and C u l t u r e ,  the  D epar tm ent  o f  R e l i g i o u s  A f f a i r s ,  t h e  
I n d o n e s i a n  P la nned  P a r e n t h o o d  A s s o c i a t i o n ,  the  Muhammadiyah (Moslem 
A s s o c i a t i o n ) ,  t h e  I n d o n e s i a n  C ou n c i l  o f  Churches and the  Women's 
O r g a n i z a t i o n .
1.3*6  I n f o r m a t i o n ,  E d u c a t i o n  and Communication
The I n d o n e s i a n  I n f o r m a t i o n ,  E d u c a t i o n  and Communicat ion ( lEC) 
a c t i v i t i e s  aim to  e n c o u ra g e  the  p u b l i c  to  u n d e r s t a n d  and f o l l o w  the  
f a m i l y  p l a n n i n g  program. The i n d i c a t e d  pu rpose  i s  f a m i ly  and community 
w e l f a r e  t h rough  the  a c c e p t a n c e  o f  the  "Sm al l ,  Happy and P r o s p e r o u s  
Family"  norm. The a p p ro a c h e s  t a k e n  i n  the l a s t  decade  i n c l u d e  mass 
i n f o r m a t i o n ,  g roup  m e e t i n g s ,  and i n d i v i d u a l  f a c e  to  f a c e  comm unica t ion .  
IEC a c t i v i t i e s  f o l l o w  t h r e e  d i f f e r e n t  fo rm s ,  a l l  o f  which a r e  t a r g e t  
o r i e n t e d .  Those d i r e c t e d  to  the  masses  use t h e  mass media ,  w i th  the
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community at large as its target. Those aimed at the group level involve 
meetings with pre-selected targets. The third form is face to face 
encounters, where field workers, family planning motivators, and village 
contraceptive distribution center personnel (volunteers) go from door to 
door to contact individuals.
Mass media channels include radio and television, film, news 
papers, family planning information mobile units, traditional media, 
various publications, billboards, lightboxes, video cassette recorders 
and so on. These are funded both by the government and various 
sponsoring agents abroad such as the World Bank, UNFPA, USAID.
Finally, there is the more intimate and private approach of face to 
face meetings through door to door family visits by Family Planning 
Field Workers, and visits with community leaders in the villages. This 
face to face approach is meant to stimulate the formation of local 
acceptor groups.
1*3*7 Contraceptive Services
Contraceptive services are intended to help establish new family 
planning behaviour by upgrading the quality of services, by increasing 
the number of contraceptive methods available and by enlarging the 
number of service sites with simple procedures and effective and 
inexpensive contraceptive devices. The Program offers contraceptive 
services at multiple sites through:
(a) clinical services in hospitals, family planning clinics, 
mobile medical teams, and
(b) non-clinical services by family planning field workers, 
private doctors, private midwives, village contraceptive distribution 
centers (VCDCs), and commercial channels. The contraceptive devices 
available are primarily pills, IUDs, condoms, injectables and also other 
methods. However, in an effort to bring family planning services closer 
to the people, the NFPCB extended its service delivery infrastructure 
down to the village level through its mobile medical teams and the 
community based family planning program. Now the NFPCB possesses a 
service delivery infrastructure that extends from the health centers to
60,000 villages in the country. The NFPCB has manpower at the village 
level consisting of village contraceptive distribution centers (VCDCs) 
in each village staffed by volunteers and managed by village organized 
acceptor groups. NFPCB fieldworkers, one for every three villages, 
supervise the VCDCs and the district health centre.
I. 3*8 Acceptance and continuation
The Program began in 1969/1970, and after the first two years the 
numbers recruited reached over one million. They doubled by 1975/1976 to 
about two million, and have exceeded that level in each subsequent year, 
as annual achievements have essentially met or exceeded the target set.
The current Program policy is to encourage acceptors to try the 
IUD, as a means of reducing the heavy costs and logistical complications 
of pill distribution. IUD acceptance has indeed risen in recent years. 
The other methods, vaginal tablets, injection, and medical operations or 
sterlization (still on clinical trials) have always played a minor role, 
but the latter two, injection and medical operation, have grown to 
account for about 25 per cent of all acceptors.
As a result of rising acceptance rates and continuation rates, the 
prevalence of contraception use rose rapidly. By 1983/1984 over 66 per 
cent of couples in Java and Bali were using a method, with East Java 
province approaching 71 per cent. In Outer Islands I, where the Program 
did not begin until the mid 1970's, prevalence was 51 per cent by 
1983/1984, with North Sulawesi the highest at 64 per cent. Outer Islands
II, brought into the program in 1979/1980, had 24 per cent prevalence in 
1983/1984, with Bengkulu province at 49 per cent. Altogether, by 
1983/1984 Indonesia had a countrywide prevalence of 59 per cent, and 
according to monthly statiscal summary on March 1985, the prevalence 
waas 62.6 [NFPCB, 1985: l].
1.4 The Data Set and their limitations
This study is based on three sets of data. The first source is the 
results of a fieldwork case study in Jakarta, Bandung and Yogyakarta.
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This  s t u d y ,  conduc ted  by the  a u t h o r  i n  J a n u a r y  -  F e b r u a r y  1985, was o f  
DP u s e r s  who were s t i l l  p r o t e c t e d  by DP a t  the  t ime  o f  i n t e r v i e w .  I t  
f ocuse d  on the  a c c e p t a b i l i t y ,  the  m o t i v a t i o n  i n  u s a g e ,  the  s i d e  e f f e c t s  
t h a t  commonly a f f e c t e d  u s e r s  and the  t o l e r a n c e  shown by u s e r s  to  the  
s i d e  e f f e c t s  m en t io n e d .
Th is  f i e l d  s tu d y  d id  n o t  c o v e r  t r e n d s  i n  usage  o f  DP, the  c a u s e s  o f  
t e r m i n a t i o n  in  d e p th ,  c o n t i n u a t i o n  r a t e s ,  method f a i l u r e  o r  t h e  
background o f  the  u s e r s .
The second s o u rc e  i s  t h e  Fam ily  P l a n n i n g  Modular  Survey o f  s i x  
p r o v i n c e s  o f  J a v a - B a l i .  These s u r v e y s ,  conduc ted  i n  1982-1983,  
c o n s i s t e d  o f  4 modules :
1. The s o c io - e c o n o m ic  and m i g r a t i o n  module.
2. The c o n t r a c e p t i v e  p r e v a l e n c e  and f e r t i l i t y  module.
3- The m o r t a l i t y ,  m o r b i d i t y ,  n u t r i t i o n  and h e a l t h  p r a c t i c e  module.
4.  The c o n t r a c e p t i v e  c o n t i n u a t i o n  module.
Each module i s  d e s ig n e d  to  be s e l f  c o n t a i n e d ,  and c o n s i s t e d  o f  
t h r e e  c a t e g o r i e s  o f  d a t a :  (1 )  background  d a t a  on the  r e s p o n d e n t s ,  (2 )  
pr ime d a t a ,  which b e a r  d i r e c t l y  upon the  co re  v a r i a b l e s  i n v e s t i g a t e d  i n  
the  s p e c i f i c  module,  and (3)  s u p p o r t i n g  d a t a ,  complementing the  c o re  
d a t a  and i n c r e a s i n g  t h e i r  a c c u r a c y .
For  t h i s  s t u d y ,  module 4, t h e  c o n t r a c e p t i v e  c o n t i n u a t i o n  module,  
was u s e d .  Module 4 drew i t s  sample from the  p o p u l a t i o n  o f  f a m i ly  
p l a n n i n g  a c c e p t o r s  be tween  A p r i l  1977 and March 1982. A t o t a l  sample o f  
a p p r o x i m a t e l y  2400 a c c e p t o r s  was s e l e c t e d  f o r  each  p r o v i n c e .  [NFPCB, 
1982 : 1- 2 0 ].
The Family  P l a n n i n g  modula r  s u r v e y s  were made i n  1982, bu t  used 
r e s p o n d e n t s  ( a c c e p t o r s )  r e c o r d e d  in  c l i n i c s  be tween  A p r i l  1977 and March 
1982. At t h a t  t ime DP u s e r s  were m o s t l y  from s h o r t  term t r i a l  p r o j e c t s ,  
o f f e r e d  in  some c l i n i c s  i n  b ig  c i t i e s  i n  Java  and B a l i .  Those s e r v i c e s  
d id  no t  r e a c h  the  r u r a l  p e o p l e ,  and th e  s t o c k s  o f  the  drug were v e r y  
l i m i t e d .  DP u s e r s  compr ised on ly  a b o u t  13 p e r  c e n t  o f  t h e  t o t a l  s am ple .  
That  i s  why the  a c c e p t a b i l i t y ,  which can be seen  from the  c o n t i n u a t i o n  
r a t e s ,  was r e l a t i v e l y  low compared to  IUDs and p i l l s .  In  o t h e r  s t u d i e s  
t h e  c o n t i n u a t i o n  r a t e s  were comparab le  w i th  p i l l s  and IUDs, and even 
b e t t e r  [B a ldw in ,  1982: 7;  B a r t e n ,  1973: 2 ] .  F u r th e r m o r e ,  as  t h e s e  
s u r v e y s  were d e s ig n e d  f o r  a l l  methods o f  c o n t r a c e p t i o n ,  the  q u e s t i o n s
13
asked about causes of termination were too general, and did not apply to 
the specific characteristics of DP as a contraceptive.
The third source is the Indonesian Family Planning service 
statistics. The service statistics publish trends in new acceptors and 
contraceptive current users, and prevalence levels. From these sources 
the trend of current users can be observed and the level of prevalence 
for every year and every province. The popularity and increasing 
availability of DP can be measured from rising use every year since the 
trial project period (1976).
Since the service statistics are based on the monthly reports from 
family planning clinics, they do not cover private services. (private 
doctors, private midwives and commercial channels), but these are more 
important for measuring DP use.
Current user prevalence rates are calculated by applying 
assumptions to logistic data on numbers of new acceptors or numbers of 
contraceptives distributed. For IUDs and injectables, acceptance 
involves a single event, so the recorded numbers of new acceptors should 
be reliable. But for pills and condoms, an acceptor may receive 
supplies for one month, but she/he may not use them or may waste or 
misuse them. As they are open to error, numbers of pills and condoms 
distributed may be higher than actual numbers used [streatfield, 1984:
1-9].
1.5 Organisation of the Thesis
This thesis is divided into' five chapters. The second chapter is a 
review of DP as an injectable contraceptive. Chapter Three looks at in 
the Program, and how and why the Indonesian Family Planning Program 
launched DP as a supplementary method. This chapter is based on The 
Family Planning Modular surveys and monthly Family Planning service 
statistics. The fourth chapter look at the acceptability of DP to 
Indonesian women. This chapter covers the results of field work among DP 
users in Jakarta, Bandung and Yogyakarta. Three main variables will be 
described: the acceptability, the motivation for using DP, the side 
effects included the tolerance of the side effects mentioned. From these 
results the popularity of this contraceptive can be observed and the
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future situation can be predicted. The last part consists of a summary 
and conclusion.
Figure 1-1: JAVA AFT EALI.
Note: 1. Jakarta
2. Bandung
3. Yogyakarta
1
Figure 1-2: Indonesia's Provinces Comprising The
Java-Bali, Outer Island I And Outer Island II.
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CHAPTER 2
INJECTABLES AS CONTRACEPTIVES: 
A LITERATURE REVIEW
2.1 I n t r o d u c t i o n
The g o a l  o f  c o n t r a c e p t i v e  r e s e a r c h  i s  to  d e v e lo p  an e f f e c t i v e ,  long  
a c t i n g  method t h a t  does  n o t  r e q u i r e  a c t i o n  d a i l y ,  o r  a t  each a c t  o f  
c o i t u s ,  and i s  r e v e r s i b l e .  S t e r i l i z a t i o n  p r o v i d e s  long  term p r o t e c t i o n  
a g a i n s t  p regnancy  b u t  i s  n o t  r e v e r s i b l e ,  w h i l e  IUDs p r o v i d e  long  term 
p r o t e c t i o n  and a r e  r e v e r s i b l e ,  b u t  a r e  no t  s u i t a b l e  f o r  a l l  women 
[ L i s k i n ,  1982: B—113]» Female hormones o f f e r  a n o t h e r  p o s s i b i l i t y  f o r  
r e v e r s i b l e ,  l o n g - a c t i n g  p r o t e c t i o n  a g a i n s t  p r e g n a n c y ,  b u t  t h e  s e a r c h  f o r  
a l o n g - a c t i n g  hormonal  method f r e e  from any s e r i o u s  s i d e - e f f e c t s  has  
proved d i f f i c u l t  [P o w e l l  and Seymour,  1971: 3 6 ] .
The deve lopment  o f  p r o g e s t a g e n s  ( s y n t h e t i c  compounds w i th  t h e  
e f f e c t s  o f  t h e  n a t u r a l  hormone p r o g e s t e r o n e )  grew ou t  o f  t h e  p o s t  World 
War I I  c o m p e t i t i o n  among drug  companies  t o  c r e a t e  s y n t h e t i c  hormones f o r  
a v a r i e t y  o f  t h e r a p e u t i c  p u r p o s e s .  These e a r l y  p r o g e s t a g e n s  m e t a b o l i z e d  
q u i c k l y  and t h e r e f o r e  had to  be a d m i n i s t e r e d  f r e q u e n t l y  t o  g a i n  t h e i r  
e f f e c t  [ R i n e h a r t ,  1975: K -2 ] .
In  1950, Dr Gregory  P in c u s  and h i s  a s s o c i a t e s  s t a r t e d  t o  u t i l i z e  
p r o g e s t a g e n s  f o r  f e r t i l i t y  c o n t r o l ,  c o n c e n t r a t i n g  on d e v e l o p i n g  an o r a l  
c o n t r a c e p t i v e  [ R i n e h a r t ,  1975: K -2 ] .  The f i r s t  i n j e c t a b l e  p r o g e s t i n s  
were d e v e lo p e d  i n  1953 by Kar l  Junkmann.  In  1957 Junkmann, o f  S c h e r i n g  
A.G. i n  B e r l i n ,  s y n t h e s i z e d  l o n g - a c t i n g  i n j e c t a b l e  e s t e r s  o f  t h e  
p r o g e s t i n  n o r e t h i n d r o n e  ( n o r e t h i s t e r o n e )  i n c l u d i n g  n o r e t h i n d r o n e  
e n a n t h a t e  (NET EN) [ L i s k i n ,  1982: K-5]*
The f i r s t  e f f o r t s  t o  used DP a s  a c o n t r a c e p t i v e  were t h o s e  o f  Dr. 
Cout inho from B r a z i l .  In  t h e  e a r l y  1950s and 1960s he found t h a t  t h e  
e f f e c t i v e  dose  f o r  one m o n t h ' s  c o n t r a c e p t i o n  was i n  t h e  r ange  o f  50 mg.
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One hundred and sixty mg of DP gave protection for 3 months, at 400 mg 
the effect was extended to 6 months and at 1 gram for 9-12 months. DP 
could also he used as a male contraceptive but higher doses were 
required for effective suppression of spermatogenesis [Coutinho, 1978: 
78, 402].
In the clinical trials of DP as a human contraceptive (1963), a 
standard regimen of 150 mg every three months was established. Later, 
the regimen of 300 or 400 mg every six months was also studied and 
marketed but not widely used [Mackay, et al., 1971: 148-163]* 
Combinations of a progestagen and an estrogen are distributed in a few 
countries as monthly injectables. In Chile, Recalcine Laboratories 
produce AGURIA, and Selesia Laboratories produce UNAMELS. Both are a 
combination of Dehydroxyprogesterone aceptophenide and estradiol 
enanthate [Rinehart, 1975: K-2; Koetsawang, et al., 1978: 63]* Another
widely tested monthly injectable, Cyclo-Provera, provides complete 
contraceptive protection and relatively good menstrual cycle control 
[Toppozada, 1977: 340]. The regimen currently used involves 25 mg of 
estradiol injected every 28 days [Fotherby, et al., 1982: 261]. In the 
last few years a long-lasting new injectable, Progestagen ORG-2154, was 
also tested. Using a 200 mg injection, ovulation was inhibited for five 
to ten months [Coutinho, et al., 1982: 551]•
Horigest is recommended for administration using 200 mg. at every 8 
weeks for the first six months and then every 12 weeks [Howard, et al., 
1982: 340; Goebelmann, et al., 1979: 295]* Several combinations were 
distributed in a few countries as a monthly injectable. A combination 
of algestone acethophenide and estradiol enanthate were marketed in 
Mexico and Argentina under the brand name PERLUTAL and in Spain under 
the brand name TOPASEL [Rinehart, 1975: K-2].
Since this study focuses on DP, the discussion will be centered 
only on that type of injectable, particularly on the standard regimen of 
150 mg every three months.
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2.1.1 The Depo Provera Debate
In February 1967, the Upjohn Company submitted to the FDA (US Food 
and Drug Administration) a supplemental new drug application (NDA) for 
the new use of DP as a contraceptive in USA. Approval was given for use 
in a limited patient population as an injectable, and for a 
post-marketing study to clarify the carcinogenic potential of the drug 
[Kennedy, 1978: 304]. On March 7, 1978, the FDA issued a non-approval 
letter for DP as a contraceptive for use in USA. This decision began a 
debate and controversy which is on-going at the time of writing.
The supporters of DP are primarily family planning advocates and 
program administrators, including the IPPF (International Planned 
Parenthood Federation), WHO (World Health Organization), scientists, 
doctors and the Upjohn Company. The opposition to DP includes the FDA, 
the National Women's Health Network, an alliance of US consumer health 
and women's groups, a San Francisco based group which criticized US 
development policies in the Third World, the magazine Mother Jones, the 
magazine Women and Health, and Public Advocate, a coalition of minority 
and civil rights organizations [Gold and Wilson, 1981: 37]* The 
controversy is described in detail in Appendix A and E.
The debate heated again in 1980, and another debate a rose between 
women groups, represented by Mr. Stephen Minkin (a Health Policy Analyst 
with the National Women's Health Network, USA) and several scientists 
and Medical researchers. The opposition groups have concentrated on 
using the popular media to generate opposition to DP through- charges of 
a double standard of medical care for rich and poor women, developed and 
less developed nations. For these reasons, and because of US drug laws, 
USAID was not allowed to purchase and distribute DP abroad, [DP Debate, 
1978: 203].
The FDA decision has had four main effects on service providers 
around the world:
a. The decision provided ammunition for those who still condemn 
family planning as immoral, making them, slow to authorize the drug. 
For example, although there was long experience of DP use in Sri Lanka, 
only a few thousand women have acceses to the method. Most women who do 
not use DP, are afraid of getting cancer or that DP will impaire their 
health [Potts, 1978: 233; Sai, 1978: 7].
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b .  The d e c i s i o n  h a s  i n h i b i t e d  Program a c c e p t a n c e .  For  example,  i n  
I n d o n e s i a  DP i s  o n l y  made a v a i l a b l e  to  o l d e r  women w i th  many c h i l d r e n ,  
o r  w i t h  a t  l e a s t  two c h i l d r e n  [ P o t t s ,  1978: 234]*
c .  The d e c i s i o n  means USAID c a n n o t  s u p p l y  DP and t h i s  s lows  
e x p a n s io n  o f  u s e ,  [ S a i ,  1978: 7]*
d .  The p u b l i c i t y  a r i s i n g  i n  t h e  USA from t h e  FDA d e c i s i o n  was 
d i s t o r t e d  i n  o t h e r  c o u n t r i e s .  Governments  i n  d e v e l o p i n g  c o u n t r i e s  used
t h o s e  d e c i s i o n s  as  a r e a s o n  f o r  s im p l y  ban n in g  t h e  d rug  [ S a i ,  1978: 7; 
P o t t s ,  1978: 2 34 ] .
2 .2  The Usage o f  I n j e c t a b l e s  a s  C o n t r a c e p t i v e s  o u t s i d e  I n d o n e s i a .
I n j e c t a b l e  c o n t r a c e p t i v e s  a r e  now l e g a l l y  p e r m i t t e d  i n  many 
c o u n t r i e s ,  and by f a r  t h e  most  w i d e l y  used  and b e s t  known i s  DP [Maine,  
1978: 342;  Kane, 1983: 7 2 ] .  The d e c a d e - l o n g  c o n t r o v e r s y  c e n t r e s  on the  
s a f e t y  o f  DP a s  a c o n t r a c e p t i v e ,  b u t  t h e  f a c t s  show t h a t ,  w h i l e  n o t
approved  i n  t h e  USA, i t  i s  app roved  f o r  u se  i n  more t h a n  80 c o u n t r i e s ,  
i n c l u d i n g  more t h a n  10 c o u n t r i e s  i n  Weste rn  Europe [ P o t t s ,  1984: 10 ] .
In  i t s  1978 d e c i s i o n ,  t h e  FDA n o te d  t h a t  b e n e f i t - r i s k  
c o n s i d e r a t i o n s  a r e  n o t  t h e  same i n  a l l  c o u n t r i e s  o f  the  w o r ld .  In  an 
e c o n o m i c a l l y  d e v e lo p e d  n a t i o n  l i k e  t h e  USA, w i th  an advanced  h e a l t h  c a r e  
sys tem ,  t h e  d i s a p p r o v a l  judgem ent  i s  a p p r o p r i a t e .  The o p p o s i t e  d e c i s i o n  
may be more a p p r o p r i a t e ,  however ,  f o r  n a t i o n s  w i th  h i g h e r  b i r t h  r a t e s ,  
lower  p h y s i c i a n - p a t i e n t  r a t i o s ,  and l e s s  r e a d i l y  a v a i l a b l e  c o n t r a c e p t i v e  
methods [Gold ,  1981: 3 6 ] .
Thus, t h e  d e b a t e  c o n t i n u e s ,  b u t  t h e  use  i n c r e a s e s  [ R i n e h a r t ,  1975: 
K -1 : Maine, 1978: 1; Gold,  1981: 35-37]*  The c o u n t r i e s  which approved  
DP a s  a c o n t r a c e p t i v e  a r e  shown i n  Tab le  2 - 1 .
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Table 2-1: Countries in which depo medroxyprogesterone acetate
is marketed as a contraceptive.
Africa Asia and 
the Pacific
Europe Latin America Middle East
Cameroon Bangladesh Belgium Argentina Bahrain
Ethiopia Burma Denmark Antigua Cyprus
Ghana Hong Kong England Barbados Iraq
Guyana Malaysia France Bolivia Kuwait
Kenya New Zealand Vest Bermuda Lebanon
Liberia Pakistan Germany Colombia Muscat & Oman
Libya Philippines Iceland Chile Qatar
Malagasy Singapore Luxembourg Costa Rica Saudi Arabia
Malawi Sri Lanka Nether- Ecuador Syria
Morocco Thailand lands El Savador United Arab
Negeria Khmer Norway Grenada Emirates
Reunion Korea Portugal Guatemala Afganistan
Rhodesia Sabah Spain Haiti Iran
Rwanda Serawak Sweden Honduras
Sierra Vietnam Switzer- Jamaica
Leone China land Mexico
South Yugoslavia Nicaragua
Africa Panama
Sudan Paraguay
Lesotho Peru
Tanzania Surinam
Tunisia Trinidad &
Egypt Tobago
Seychelles St.Kitts
Uganda St.Lusia
Mauritius
Zaire
Zambia
Zimbabwe
St.Vincent
Sources: Liskin, 1982: K—14; Potts and Paxman, 1984: 10.
2.3 Advantages of Depo Provere^
Eased on the extensive epidemiological, biochemical, and clinical 
data available to date, DP appears to be an acceptable method of 
fertility regulation. Clinical evidence from more than 15 years of use 
shows no additional, and possibly fewer, adverse side effects than are 
found with other hormonal methods of contraception. The particular 
advantages of DP as highly effective, long lasting , and reversible make 
it an important option for women desiring a method of fertility 
regulation [VHO, 1982: 199]*
From the users point of view, DP is attractive. Reports from
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fam i ly  p lann ing  programs everywhere show t h a t ,  where women were o f f e r e d  
a cho ice o f  c o n t r a c e p t i v e  methods which in c luded  an i n j e c t a b l e ,  between 
one q u a r t e r  and t h r e e  q u a r t e r s  chose the  i n j e c t a b l e  [Mackay, e t  a l ,  
1971 : 155; McDaniel and P a r d t h a i s o n g , 1974: 175]* E f f e c t i v e n e s s ,  
conven ience ,  r e v e r s i b i l i t y  and freedom from f e a r  o f  f o r g e t t i n g  [Dodds, 
1975: 15],  and the f a c t  t h a t  husbands cannot  i n t e r f e r e  w i th  i t s  use a re  
major r easons  f o r  the  p o p u l a r i t y  o f  DP [Me Danie l  and P a rd th a i s o n g ,  
1974: 175]* The mode o f  a d m i n i s t r a t i o n  i s  a l s o  an a s s e t  [Dodds, 1975: 
22],
Another im por tan t  advan tage  i s  t h a t  DP does no t  i n h i b i t  l a c t a t i o n  
as  the  p i l l  sometimes does .  In f a c t  DP may a c t u a l l y  i n c r e a s e  both  the 
d u r a t i o n  o f  l a c t a t i o n  and the  volume o f  m i lk .  I t  i s  t h e r e f o r e  
p r e f e r a b l e  f o r  pos tpar tum use ,  e s p e c i a l l y  in  c o u n t r i e s  where mothers 
b r e a s t  feed t h e i r  c h i l d r e n  f o r  long p e r io d s  [Benagiano and F r a s e r ,  1981:
512].
A c o n t r a c e p t i v e  which does no t  reduce  l a c t a t i o n  i s  welcome f o r  two 
re a s o n s .  F i r s t l y ,  i t  can be o f f e r e d  to  women in  the  pos tpar tum p e r io d ,  
a time when women may be m ot iva ted  to acc e p t  c o n t r a c e p t i o n .  Secondly,  
c o n t r a r y  to popu la r  tho u g h t ,  o v u l a t i o n  and concep t ion  can occur  be fo re  
the end o f  l a c t a t i o n  amenorrhoea so l a c t a t i n g  women need c o n t r a c e p t i o n  
as  e a r l y  as p o s s i b l e  [Ginneken,  1974: 204] .  The method o f  
a d m i n i s t r a t i o n  i s  a l s o  a g r e a t  advan tage ,  compared to IUDs. Most r u r a l  
and r e l i g i o u s  (Moslem) women s t i l l  r e j e c t  the  exposure o f  t h e i r  g e n i t a l  
organs to  s t r a n g e r s ,  even medical  p e r s o n n e l  [Lubis  and P r i h a r t o n o ,  1984:
5].
I n j e c t a b l e s  have g r e a t  p o t e n t i a l  f o r  wider  d i s t r i b u t i o n  and u se .  
DP can be s to r e d  w i thou t  r e f r i g e r a t i o n  f o r  up to  f i v e  y e a r s  [R in e h a r t ,  
1975: K-12].  Paramedica l  p e r s o n n e l  can e a s i l y  g ive  i n j e c t i o n s .  
Dropping the  requ i rem en t  t h a t  a women have a p e l v i c  exam inat ion  be fo re  
r e c e iv in g  an i n j e c t i o n  would broaden i t s  a ccep tance  in  many a r e a s  [Me 
Daniel ,  1974: 179].
2.4 The E f f e c t i v e n e s s  and C o n t in u a t io n  r a t e s  o f  Depo Provera
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2.4*1 The E f f e c t i v e n e s s  o f  Depo P r o v e ra
The s t a n d a r d  d o s e s  o f  DP (150 mg f o r  t h r e e  months )  o f f e r  h i g h l y  
e f f e c t i v e  p r o t e c t i o n  a g a i n t s  p r e g n a n c y .  Accord in g  to  some s t u d i e s ,  DP 
p r e v e n t s  p regnancy  i n  s e v e r a l  ways.  These a r e  p r i m a r i l y :  i n h i b i t i n g  
o v u l a t i o n  by s u p p r e s s i n g  t h e  FSH and LH r e l e a s e  [ S a l e h ,  e t  a l . ,  1983: 
48;  Mackay, e t  a l . ,  1971: 245;  Goebelmann,  e t  a l . ,  1979: 297; Kane, 
1983: 7 1 ] ,  making c e r v i c a l  mucus t h i c k ,  t h u s  c r e a t i n g  a b a r r i e r  to  sperm
[Mackay, e t  a l . ,  1971:  156; Mahgoub and Karim, 1972: 21-29]* 
F u r th e r m o r e ,  i t  make t h e  endomet r ium l e s s  s u i t a b l e  f o r  t h e  i m p l a n t a t i o n  
o f  f e r t i l i z e d  ovum [Mahgoub and Karim,  1972: 21 -2 9 ;  Me D a n i e l ,  1974: 
177] ,  and p o s s i b l y  changes  t h e  r a t e  o f  ovum t r a n s p o r t  t h ro u g h  t h e  
o v i d u c t s  [Mackay, e t  a l . ,  1971: 232;  Me D a n i e l ,  1974: 177] .
The e f f e c t i v e n e s s  o f  i n j e c t a b l e s ,  p a r t i c u l a r l y  DP, may v a r y ,  
d e pe nd ing  on:  t h e  t im e  o f  t h e  i n j e c t i o n ,  t h e  r a t e  o f  m e ta bo l i sm  o f  t h e  
d rug ,  t h e  women's w e ig h t  and t h e  i n j e c t i o n  t e c h n i q u e .  To e n s u r e  t h a t  a 
women i s  n o t  p r e g n a n t  when she  i s  i n j e c t e d ,  i t  i s  w i d e ly  recommended 
t h a t  i n j e c t a b l e s  be a d m i n i s t e r e d  d u r i n g  t h e  f i r s t  f i v e  to  seven  days o f  
a woman's m e n s t r u a l  c y c l e  [Pow e l l  and Seymour,  1971: 30;  Eenag iano and 
F r a s e r ,  1981: 514; S i r i w o n g s e ,  e t  a l . ,  1982: 4 9 2 ] .  I n j e c t i o n s  g i v e n  
e a r l y  i n  t h e  c y c l e  may be more e f f e c t i v e  i n  p r e v e n t i n g  c o n c e p t i o n .  Most 
a c c i d e n t a l  p r e g n a n c i e s  o c c u r  e i t h e r  s h o r t l y  a f t e r  t h e  f i r s t  i n j e c t i o n ,  
o r  j u s t  b e f o r e  t h e  end o f  an i n j e c t i o n  i n t e r v a l  when i t s  e f f e c t s  has  
begun to  wear  o f f  [ R i n e h a r t ,  1975: K -4 ] .
Pregnancy  r a t e s  (method f a i l u r e s )  have been c o n s i s t e n t l y  low,  wi th  
0 .4  p e r  100 women y e a r s  [WHO, 1983: 3]* In  t h e  l a r g e  s c a l e  
c o l l a b o r a t i v e  s t u d y  o f  3 ,857  US and L a t i n  American women, t h e  c u m u l a t i v e  
f a i l u r e  r a t e  c a l c u l a t e d  by t h e  l i f e  t a b l e  t e c h n i q u e  was 0.31 p r e g n a n c i e s  
p e r  100 women y e a r s  and ranged  up t o  0 . 9 0  f o r  36-70 months [ C i t e d  by 
Upjohn,  1978: 2 7 9 ] .  Thus c u r r e n t l y  a v a i l a b l e  d a t a  i n d i c a t e  t h a t  DP i s  
more e f f e c t i v e  t h a n  o r a l  c o n t r a c e p t i v e  t a k e n  r e g u l a r l y  ( w h i t  f a i l u r e  
r a t e s  o f  a b o u t  2 p e r  hundred  women y e a r s )  [ R i n e h a r t ,  1975: A -53 ] ,  and 
m ark e d ly  more e f f e c t i v e  t h a n  IUDs ( w i t h  f a i l u r e  r a t e s  r a n g i n g  from 1 .7  -  
5*8 p e r  hundred  women y e a r s ) [ L i s k i n ,  1982: B -103 ] .
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2.4*2 The Continuation Bates of Depo Provera
The continuation rates of DP have been found to vary markedly among 
different populations, ranging from 50 per cent to nearly 90 per cent at 
one year of use and 40 per cent to 68 per cent at two years of use 
[Nash, 1975: 377].
Women may find menstrual disturbances upsetting, because it is 
often thought that irregular or excessive bleeding is a symptom of 
sickness or that amenorrhoea is a sign of pregnancy. Eeligious 
practices, folk beliefs, and rumors may also contribute to a women's 
concern [Mahgoub and Karim, 1971: 741]. Despite the side effects of DP, 
60 per cent or more of all users can be expected to continue with the 
method for at least one year [Einehart, 1975: K-7; Narkavonnakit, et 
al., 1982: 101]. But with good counselling and better quality services, 
"DP continuation rates in Thailand are at least comparable to pills and 
IUD", i. e. 70 per cent for the first year and 57 per cent for the 
second year of use [Baldwin, 1978: 304]. Even in Bangladesh DP 
continuation rates were considerably higher than those for the pill 
[Huber, 1976; 249]* If fear can be eliminated, many women will tolerate 
side effects. Poor nutrition and short birth intervals in developing 
countries may make regular menstrual patterns the exception rather than 
the rule. Clinicians from various areas report that many women actually 
are pleased by the absence of menstruation [Einehart, 1975: K-8]. The 
continuation rates of DP mostly depend on the easy availability of other 
methods, education, cultural factors and the availability of DP itself 
[Baldwin. 1978: 305], (see Figure 2.1).
2.5 The Side Effects of Depo Provera.
Like all other contraceptives, DP has a series of important 
side-effects that users should understand. In a great majority of 
users, injectables cause serious alterations in uterine bleeding and 
most women, after prolonged use, have long intervals of amenorrhoea. 
Weight-gain can also be associated with the use of the drug [McDaniel, 
1980: 15; Ali, 1978; 63- 70].
Menstrual cycle disruptions: All progestagens, but especially
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injectables, disrupt menstrual patterns. Women using injectables may 
experience shorter or longer cycles, increased or decreased menstrual 
flow, and spotting [Mahgoub and Karim, 1972: 25; McDaniel and 
Pardthaisong, 1974: 178]. Much more upsetting may be irregular bleeding 
and spotting. This can be a real drawback for women whose culture or 
religion limits their activities when they are bleeding, and it may
increase anaemia [Kane, 1983: 73]* Generally, over two thirds of women 
using DP have no regular cycles in the first year of use. Menstrual 
effects depend on the length of use. Inter-menstrual bleeding and 
spotting decrease with time, whereas amenorrhoea increases [Ali, 1978: 
65: Swenson, 1980: 210]. Heavy bleeding, a potential health threat, is 
rare. In the first WHO multi-centre trial, only 6 of 1,214 women, or 
0.5 per cent required treatment for either heavy or prolonged bleeding 
during 13,800 women-months of use [WHO, 1978: 1-7]* Changes in 
menstrual patterns are largely unpredictable. Amenorrhoea appears to be 
more common in DP users with greater body weights [Chinnatamby, 1971: 
234-235].
Management of Bleeding: It was originally believed possible to 
overcome some of those menstrual disruptions by administering estrogen 
supplements (either orally or by injection). Estrogen has proved to be 
of value in suppressing excessive and irregular bleeding and is also 
capable of inducing menstrual-like bleeding in amenorrhoeic subjects 
[Toppozada, 1978: 441 ]• But a recent study has shown that careful 
counselling of acceptors has allowed the omission of estrogen 
supplements. Since one of the advantages of the injectable is its 
absence of estrogen, skillful and periodic counselling is needed to help 
clients accept whatever de.'ree of menstrual disruptions they may 
experience [Baldwin, 1978: 303]*
Weight gain: this may be an advantage to some and disadvantage to 
others, and occurs in the majority of DP users. In clinical studies 
mean weight gain has ranged from 1.4 pounds to 9*0 pounds in the first 
year of use, but then it stabilizes or decreases [Chinnatamby, 1971: 
230; Leiman, 1972: 99]-
Cardiovascular effects: DP appears to have little effect on either 
blood pressure or blood regulation. Most studies show no significant 
change in systolic and diastolic blood pressure in women using DP [Ali,
24
1978: 69; Chinnatamby, 1971: 225; Kackay, e t  a l . ,  1971: 225; Powell and 
Seymour, 1971: 59] •
Other s i d e - e f f e c t s :  Other com pla in t s  r e p o r te d  by u s e r s  o f  DP 
in c lu d e  nausea ,  d i z z i n e s s ,  headaches ,  ne rv o u sn ess ,  c h i l l s ,  change in  
sk in  p ig m en ta t io n ,  p a i n f u l  m e n s t r u a t io n ,  l e s s e n i n g  o f  l i b i d o ,  d im in ished  
orgasm and acne .  How o f t e n  th e s e  s i d e - e f f e c t s  occur  and what p ro p o r t i o n  
o f  u s e r s  ex per i ence  them, v a r i e s  from one s tudy  to  the nex t  as  t h e se  a re  
o f t e n  h ig h ly  s u b j e c t i v e  symptoms. G e n e ra l ly ,  however, t h e se  s id e  e f f e c t s  
a re  ve ry  r a r e  [Mackay, e t  a l . ,  1971: 152].
E f f e c t  on b r e a s t - f e d  i n f a n t s :  DP does no t  appear  to  have any 
d e l e t e r i o u s  e f f e c t s  on the  q u a n t i t y  o r  n u t r i t i v e  va lue  o f  b r e a s t  mi lk .  
As mentioned,  some s t u d i e s  have sugges ted  an i n c r e a s e  in  the  q u a n t i t y  of  
b r e a s t m i l k .  I t  should be noted t h a t  the q u a n t i t y  o f  s t e r o i d  r ece iv ed  by 
the  i n f a n t  i s  c o n s id e r a b ly  l e s s  than the  amount o f  e s t r o g e n  to  which 
c h i l d r e n  b o t t l e - f e d  with  cows milk  a re  exposed [ V orhe r r ,  1975: 1011; 
WHO, 1982: 205-206; Fotherby ,  e t  a l . ,  1985: 405] .  Other s t u d i e s  o f  
c h i l d r e n  r e p o r te d  no d i s c e r n i b l e  e f f e c t s  o f  exposure to DP in  
b r e a s t m i l k ,  no d i f f e r e n c e  in  growth o r  p h y s i c a l  o r  menta l  development in  
c h i l d r e n  o f  DP u s e r s  and non u s e r s  fo l lowed  f o r  up to 4-5 y e a r s ,  and no 
d e t e c t a b l e  p h y s i c a l ,  m en ta l ,  o r  bone a b n o r m a l i t i e s  in  c h i l d r e n  whose 
mothers  had used DP [Benagiano and F r a s e r ,  1981: 516].
2 .6  F e r t i l i t y  Re la ted  E f f e c t s
The r e t u r n  to  normal m e n s t r u a t io n  and f e r t i l i t y  i s  u s u a l l y  delayed  
f o r  a few months a f t e r  d i s c o n t i n u i n g  the  drug.  Although a 150 mg 
i n j e c t i o n  i s  not  cons ide red  e f f e c t i v e  as  a c o n t r a c e p t i v e  f o r  more than  
90 days ,  i n  most women DP p r e v e n t s  pregnancy f o r  a longe r  p e r io d .  In a 
l a r g e  s tudy  o f  Thai women who s topped  c o n t r a c e p t i o n  to  become p regnan t ,  
the median de lay  to conce p t ion  was 5*5 months ( p lu s  the  e s t im a te d  
d u r a t i o n  o f  the  e f f e c t  o f  the  l a s t  i n j e c t i o n  o f  DP) , [P a rd th a i so n g ,  
1984: 25] ,  compared with  4 .5  months f o r  former IUD u s e r s  and 5 months 
f o r  former p i l l  u s e r s .  The p r o p o r t i o n  o f  women who did  no t  conce ive 
w i th in  9 months a f t e r  d i s c o n t i n u a t i o n  o f  DP i s  s i m i l a r  to t h a t  o f  ex-IUD 
u s e r s ,  and by 5 y e a r s  s i m i l a r  to t h a t  o f  the  e x - p i l l  u s e r s .  There i s  no 
ev idence  to sugges t  t h a t  pro longed use o f  DP i n c r e a s e s  de l a y s  in  
concep t ion  [ P a r d th a i s o n g ,  1984: 25]»
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No evidence suggests that DP permanently impairs fertility. More 
than 50 per cent of women are menstruating six months after 
discontinuation and about 85 per cent by one year after, suggesting that 
fertility has returned [Basnayake, 1981: 7]. Over 60 per cent of women 
become pregnant within one year after discontinuation, and over 90 per 
cent within two years [Barten, 1982: 4]. A Thai study found that by two 
years after discontinuaton 92 per cent of the DP users, 93 per cent of 
the IUD users, and 95 per cent of pill users had become pregnant. These 
differences are not statistically significant. Furthermore, there were 
no significant differences between those who conceived immediately after 
discontinuation and those who conceived later; nor between those who 
used it for a shorter period as compared with those who used it for 
longer [Pardthaisong, 1984: 32].
2.7 The Current Status of Depo Provera
Many investigators, particularly those interested in family 
planning, have studied the clinical use of DP (especially 3 month and 6 
month injections) in various parts of the world. Hundreds of 
publications have reported on almost every conceivable aspect of the 
pharmacology, toxicology and clinical use of this drug. Up to 1981, 900 
references about DP were available [Fraser and Weisberg, 1981: 3-19]*
All available evidence on the safety of DP has been reviewed in 
detail on three separate occasions by the FDA's Advisory Committees on 
Epidemiology and Biometry. All scientists, researchers and family 
planning officers who gave testimonies to The US House of 
Representatives Select Committee on Population, August 8, 9 and 10, 
1978, advised the FDA to approve the used of DP as a contraceptive [DP 
Debate, 1978: 1-789].
Data on DP have also been analyzed in depth by:
- World Health Organization (WHO) Toxicology Review panel to the 
Special Program of Research in Human Reproduction. Their study was 
conducted in 15 developed and developing countries.
- A Special ad hoc Consultative Panel convened by the Us Agency for 
International Development.
- The International Medical Advisory Panel of the International 
Planned Parenthood Federation (IPPF).
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A l l  t h e s e  n a t i o n a l  and i n t e r n a t i o n a l  b o d i e s  have conc luded  t h a t  
t h e r e  a r e  no t o x i c o l o g i c a l  o r  m e d i c a l  r e a s o n s  f o r  d i s c o n t i n u i n g  t h e  use 
o f  DP a s  a c o n t r a c e p t i v e  [E enag iano  and F r a s e r ,  1981: 497]*
A l l  FDA r e a s o n s  f o r  r e f u s a l  were s e v e r e l y  c r i t i c i s e d  d u r i n g  the  
August  1978 H ea r ing  o f  t h e  US House o f  R e p r e s e n t a t i v e s  S e l e c t  Committee 
on P o p u l a t i o n .  Of f i v e  r e a s o n s ,  f o u r  were no t  based  on s o l i d  e v id e n c e  
( r e a s o n s  no:  2, 3,  4,  5, s e e  a p p e n d ix  A).  The i n c i d e n c e  r a t e  o f  
c e r v i c a l  c a n c e r  ( r e a s o n  no :  1) i s  s t i l l  comparab le  w i th  IUD and p i l l  
u s e r s .  A s tu d y  i n  1972 showed 1 p e r  1000 u s e r s  [E e n a g ia n o ,  1978: 2 0 3 ] ,  
and a n o t h e r  s t u d y  showed 3*8 p e r  1000 women y e a r s  [ S e nana ya ke ,  1978: 
339]* I t  seems t h e r e f o r e  t h a t  t h e  USFDA may n o t  have p r o p e r l y  e v a l u a t e d  
the  r i s k s  v e r s u s  t h e  b e n e f i t s  o f  u s i n g  DP, b e f o r e  d e c i d i n g  to  r e f u s e  the  
m a r k e t i n g  a p p l i c a t i o n s .  A l l  d rug  use  e n t a i l s  some r i s k s  and the  
r e l e v a n t  q u e s t i o n  f o r  t h e  u s e r  o r  t h e  p h y s i c i a n  i s  w h e th e r  such r i s k s  
a r e  commensurate  w i th  t h e  b e n e f i t s .  DP i s  n o t  a p e r f e c t  c o n t r a c e p t i v e  
no r  i s  i t  f r e e  o f  p r o b le m s .  However, one c a n n o t  i g n o r e  t h e  f a c t  t h a t  i n  
many s o c i e t i e s ,  e s p e c i a l l y  o u t s i d e  Western  c o u n t r i e s ,  women a p p e a r  to  
f i n d  DP an a c c e p t a b l e  c o n t r a c e p t i v e  and some t im es  even p r e f e r  i t  to  
o t h e r  methods  [McDaniel ,  1980: 4;  Ba ldwin ,  1982: 6; E a r t e n ,  1984: 3]* 
Eased on c u r r e n t  knowledge ,  DP i s  a s a t i s f a c t o r y  c o n t r a c e p t i v e  w i th  
s e v e r a l  a d v a n t a g e s  and some d i s a d v a n t a g e s ,  and p ose s  no more u n r e s o l v e d  
p rob lem s  than  o r a l  c o n t r a c e p t i v e s  [E e n ag ia n o  and F r a s e r ,  1981: 495]»
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CHAPTER 3
DEPO PROVERA IN THE INDONESIAN FAMILY PLANNING PROGRAM.
3*1 Introduction
Conditions in the early 1970s appeared relatively favourable for 
family planning program development. Fast population growth and 
density, and socio-economic development had prepared for a large scale
change in reproductive behaviour. The long standing, relatively high 
position of women in Indonesia, as in all of South East Asia, was 
conducive to the introduction of modern fertility limitation. The 
culture supported a system in which a central authority could provide 
strong leadership for broad social change. Since 1966, the government 
has made a major and largely successful effort to develop an
administrative system that functions as an effective instrument of state 
policy [Sumbung, 1981: 18].
A strong conditions were important, they were only enabling 
conditions. They reflected a society ready for change and a government 
mobilized to direct change, '’especially toward fertility limitation. 
Government and society still, however, had to develop specific 
strategies and means for fertility reduction. Providing these mechanisms 
was the task of the national family planning program and its 
administrative structure, the NFPCB [Rohadi, et al., 1977: 7].
The demand for contraceptiion began long before the official family 
planning program started. In villages countless mothers who wanted to 
avoid another pregnancy had tried traditional devices; herbs, massage, 
long periods of abstinence, and long durations of lactation. Some 
succeeded and some did not. For the unlucky ones, abortion was the last
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resort to terminate their pregnancy with the risk of untimely death. 
Considering this unfortunate situation the accessibility and 
availability of effective contraceptives through the family planning 
program eased the burden for those who want to control their fertility, 
and fortunately, the government provided what the people needed.
After more than a decade of implementation, at the end of March 
1985 the program had recruited 18.7 million acceptors, of whom 15*7 
million were current users. [NFPCB, 1984: 1-3]* Although this progress
was encouraging, it was not without challengers.
Every year the numbers of married women in the reproductive ages 
(MWRA) increases by some 600,000 to 1 million women so that the incoming 
new MWRA exceed outgoing MWRA by more than 7 to 20 times. This trend has 
forced the program to exert extra effort to recruit more acceptors 
[Haryono Suyono, 1984: 2].
The trend is that new acceptors will have the characteristics of 
low parity and younger age. In 1971/1972 the average age of new 
acceptors in Java and Bali was 29*5 years, and declined to 25*03 in 
1982/1983* For Outer islands I the median age figures were 30.18 in 
1974/1975 and 26.79 in 1982/1983* The number of living children of new 
acceptors is also declining. The Java-Bali median parity was 3*77 in 
1971/1972 and only 2.05 in 1982/1983* For Outer Islands I the median 
living .children figures were 4*2 in 1974/1975 and 3*0 in 1982/1983 
(Figure 3* 1) These acceptors have a tendency to drop-out for the 
purpose of having another child. after a short duration of using
contraceptives. Controlling their reproductive behaviour is difficult 
unless they accept the small family norm [Poedjo Rahardjo, 1984: 14;
NFPCB, 1982: 101].
There are still some groups in Indonesian society who are reluctant 
to respond to the Program. They are mostly uneducated rural and 
religious people, who do not want to use any method if their religious 
leader does not approve. Some religious leaders still do not approve 
methods which need the exposure of female genital organs when 
administered, and methods which interfere with sexual activities
(barrier methods). At the same time, some women will not agree to
swallow pills every day [Haryono Suyono, 1984: 2].
Success in recruiting acceptors alone is not enough. New acceptors
29
must be sufficiently satisfied with their contraceptive method to want 
to continue practicing family planning. The methods with the longest 
continuation rates will ultimately have greatest impact upon fertility. 
Satisfaction with contraceptive methods and continuation will ultimately 
depend upon their effectiveness, convenience, appropriateness, approval 
by religious and cultural leaders, and whether they are within the grasp 
of all people and widely available.
Accordingly, the Program began trials of injectable contraceptives. 
It was hoped that this new method would meet the above requirements,
satisfy users and increase participation and continuation.
3.2 Steps in the introduction of Depo Provera
3.2.1 First awareness of Depo Provera
As in other countries, it is not easy to change a pro-natal 
community where children are highly valued from the economic, 
sociological, and psychological stand point to accept a "Small, Happy 
and Prosperous Family" norm.
Samekto [1984: 3] points out that four main factors affect the 
fertility rate: abortion, sterilization, the use of contraception and 
delayed marriage. Up to now, only one of these four, the use of 
contraception has been actively promoted in Indonesia, while the other 
three factors are still awaiting justification, legalization and action.
At present, the main efforts aims to ensure that contraceptives are 
used by more people, by their own choice, starting as early as possible 
in marriage, and for a longer time and with the minimum risk of side 
effects and failure. However, especially in villages, Indonesia still 
faces ignorance, poverty and lack of proper education and discipline, 
particularly in family planning practices. This leads to many drop-outs 
in contraceptive use and method failures.
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3 . 2 . 2  Independent  C l i n i c a l  S tu d ie s
In In d o n es ia ,  Depo Medroxy P ro g es te ro n e  A ce ta te  (DMPA), was used as 
a medica l  t r e a tm e n t  o f  v a r io u s  c o n d i t i o n s ,  such as b r e a s t  cance r ,  
p remature  l a bou r  and endom et r ia l  t r e a t m e n t .  [ S a b i r i n ,  1976: 2 ] .  I t s  use 
as a c o n t r a c e p t i v e  i n i t i a l l y  took p la c e  in  some h o s p i t a l s  in  t r i a l  
s t u d i e s  conducted by g y n e a c o l o g i s t s . D e t a i l s  a re  g iven  in  Appendix C.
Up to t h i s  p o i n t ,  s t u d i e s  o f  i n j e c t a b l e s  as c o n t r a c e p t i v e s  had 
m os t ly  been by o b s e r v a t i o n ,  i n t e r v i e w  and r e c a l l  o f  ex p e r i en ce .  
Pregnancy r a t e s ,  s i d e  e f f e c t s ,  c o n t i n u a t i o n  r a t e s  and r e v e r s i b i l i t y  can 
be d e t e c t e d  by s imple  reco rd  keep ing .  Eut i n - d e p t h  a n a l y s i s ,  such as 
b r e a s t  and endom et r ia l  c a n c e r ,  serum l i p i d s ,  the e f f e c t s  on b r e a s t  milk 
and long use e f f e c t s  need l a b o r a t o r y  t r i a l s .  Ear ly  f i e l d  t r i a l s  s u f f e r e d  
from a la ck  o f  sample v a r i e t y  and were drawn in  a very  l i m i t e d  t ime to 
make a g e n e r a l  c o n c lu s io n .  E a r t en  [1976: 52] po in ted  out  t h a t  DP has 
been a v a i l a b l e  through p r i v a t e  channe ls  and s e r v i c e s  a l th o u g h  the t r i a l s  
seemed to  be s t i l l  incom ple te .  Thus c o n d i t i o n s  pushed the  KFPCB to 
c o o rd in a te  s t u d i e s  o f  i n j e c t a b l e s .  Although s t u d i e s  a re  c o n t in u in g  they 
s t i l l  s u f f e r  from under  r e p r e s e n t a t i o n  o f  a l l  Indones ian  t r i b e s  and l a ck  
coverage  o f  t e r a g o n ic  e f f e c t s  and p h y s i c a l / h e a l t h  e f f e c t s  caused by long 
term amenorrhea.
Experience over s e v e r a l  y e a r s  has shown a g r e a t  v a r i a t i o n  in  the 
r e s u l t s  o f  c l i n i c a l  t r i a l s  o f  i n j e c t a b l e s .  This  r e s u l t s  from 
d i f f e r e n c e s  i n  s tudy  d e s ig n ,  o r  from d i f f e r e n c e s  in  the  approach to  da ta  
a n a l y s i s .  With rega rd  to s tudy  d e s ig n ,  the  c o m p a r a b i l i t y  o f  d i f f e r e n t  
t r i a l s  i s  in f l u e n c e d  by the sample s i z e  employed and e s p e c i a l l y  by the  
l a c k  o f  s t a n d a r d i z a t i o n  o f  f a c t o r s  such as s u b j e c t  r e c r u i t m e n t ,  the 
c r i t e r i a  used f o r  exc lud ing  c e r t a i n  s u b j e c t s ,  the  f requency  and n a t u re  
o f  the  p rocedures  employed f o r  fo l low  up,  and the  type o f  o b s e r v a t i o n s  
made or  the  method o f  r e c o rd in g  them. Fur therm ore ,  d i f f e r e n c e s  in  
a n a l y t i c a l  approaches  and p r e s e n t a t i o n  o f  r e s u l t s  can c r e a t e  con fu s io n .
There i s ,  t h e r e f o r e ,  a need f o r  the  Program to c o o r d in a t e  a l l  the 
t r i a l s  done in  Indones ia  and u t i l i z e  the  same s t a n d a rd  methodology,  so 
t h a t  in fo rm a t io n  on f e r t i l i t y  r e g u l a t i n g  methods can be c l e a r l y  
i n t e r p r e t e d ,  and the  r e s u l t s  would be r e p r e s e n t a t i v e  o f  d iv e r s e  
p o p u la t io n s  and c o n d i t i o n s .  The Program conducted some seminar  on the
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management o f  DP. The p a r t i c i p a n t s  were chosen from medical  r e s e a r c h e r s  
and fam i ly  p lann ing  program o f f i c e r s  in vo lved  in  medical  r e s e a r c h  and 
medica l  s e r v i c e s .  D e t a i l s  o f  t h e se  seminars  a re  g iven  in  Appendix E.
3 . 2 . 3  F i e l d  T r i a l s
Based on the  recommendations o f  the  f i r s t  seminar ,  the  NFPCB 
c o o rd in a te d  the  im plem en ta t ion  o f  f i e l d  t r i a l s ,  o f f e r i n g  DP i n  s e v e r a l  
h o s p i t a l s  and c l i n i c s  under  h o s p i t a l  c o n t r o l ,  and focussed  on s ix
p ro v in ce s  o f  Java and B a l i ,  ( A p r i l  1977 to  August 1979)* The t r i a l s  
r e c r u i t e d  22,500 women, bu t  on ly  1448 women completed the  t r i a l  s e r i e s  
o f  e i g h t  i n j e c t i o n s .
Numbers comple t ing  the  t r i a l s  were:
J a k a r t a Prov ince 33 u s e r s
West Java prov ince 148 u s e r s
C en t ra l  Java Province 688 u s e r s
Eas t  Java Province 184 us e r s
Yogyakarta Province 303 u s e r s
Bal i Province 92 us e r s
Tota l  ( Java and B a l i  ) 1448 u s e r s
[NFPCB, 1979: 1 -17] .
The t r i a l s  y i e ld e d  the  fo l low ing  r e s u l t s .
1. Most u s e r s  were i n  the  young age group;  74 p e r  cen t  aged 20 to  
30. This  i s  somewhat h ig h e r  than  a c c e p t o r s  o f  a l l  methods i n  the  same 
year  (1979) f o r  Java and B a l i :  63*5 pe r  c e n t ,  [NFPCB, 1982: 100].
2. Most u s e r s  were educa ted .  S e v e n t y -e ig h t  pe r  cen t  had a t t e n d e d  
Elementary  School to Sen io r  High School.  This  was comparable with  the 
r e s u l t s  o f  modular  su rveys  f o r  Java and B a l i ,  which found t h a t  f o r  a l l  
methods the  f i g u r e  was 84 pe r  ce n t  [Poed jo  Rahard jo ,  1984: 10].
3» The c o n t i n u a t i o n  r a t e  was 71 p e r  ce n t  i n  the  f i r s t  y e a r  and 47*3 
per  cen t  in  the  second y e a r .  These r e s u l t s  were h ig h e r  than  s t u d i e s  
done by Pardoko (1974) and Sulaiman (1970) ,  which found c o n t i n u a t i o n
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r a t e s  f o r  DP o f  55 p e r  c e n t  and 5 4 . 8  p e r  c e n t  f o r  t h e  f i r s t  y e a r  and 
34 .0  p e r  c e n t  and 19*9 p e r  c e n t  f o r  t h e  second y e a r  r e s p e c t i v e l y .  
P o s s i b l y  DP had became more p o p u l a r ,  b e c a u s e  t h e  s e r v i c e s  cou ld  be 
o b t a i n e d  e a s i l y  and f r e e  o f  c h a rg e  d u r i n g  t h e  t r i a l s .
4 . Many u s e r s  s u f f e r e d  from amenorrhoea  and b l e e d i n g  ( s p o t t i n g  and 
i r r e g u l a r  b l e e d i n g ) .
Amenorrhoea, ranged  from 2 9 .6  p e r  c e n t  to  3 6 .3  p e r  c e n t  f o r  t h e  
f i r s t  to  t h e  e i g h t h  i n j e c t i o n s .  These f i g u r e s  were s i g n i f i c a n t l y  
d i f f e r e n t  from o t h e r  s t u d i e s  done i n  I n d o n e s i a .  A g o e s t in a  (1972)  and 
Pardoko (1974) found t h a t  t h e  p e r c e n t a g e  o f  amenorrhea  r o s e  from 25*7 
pe r  c e n t  to  6 0 . 0  p e r  c e n t  and 45 p e r  c e n t  to  100 p e r  c e n t  r e s p e c t i v e l y  
f o r  t h e  f i r s t  t o  e i g h t h  i n j e c t i o n s .  T h i s  v a r i a t i o n  m igh t  be due to  
s o c io - e c o n o m ic  r e a s o n s  as  most  women i n  Java  and E a l i  now have b e t t e r  
h e a l t h  and n u t r i t i o n  s t a t u s  compared t o  c o n d i t i o n  i n  t h e  1970s when 
A g o e s t in a  and Pardoko  conduc te d  t h e i r  s t u d i e s .
B l e e d in g ,  ranged  from 2 1 .6  p e r  c e n t  a t  t h e  f i r s t  i n j e c t i o n  t o  6 .4  
p e r  c e n t  a t  t h e  s e v e n t h  i n j e c t i o n .  Th i s  f i g u r e  was c om parab le  w i th  
A g o e s t i n a ' s  and P a r d o k o ' s  f i n d i n g s .
5* The p regnancy  r a t e  was 1 .5  p e r  100 women. Compared t o  WHO 
s t u d i e s ,  which found 0 . 4  p e r  100 women, t h i s  l o o k s  v e r y  h i g h  [ WHO, 1983: 
3 ] .  These r e s u l t  may be a f f e c t e d  by human f a i l u r e s / t e c h n i c a l  f a i l u r e s ,  
no t  d rug  f a i l u r e .  A c a r e f u l  i n j e c t i o n  t e c h n i q u e  i s  e s s e n t i a l ,  and i f  n o t  
a l l  o f  t h e  d rug  i s  drawn i n t o  t h e  s y r i n g e  from t h e  c o n t a i n e r ,  t h e  dose 
may be i n a d e q u a t e .  I f  t h e  drug  i s  n o t  i n j e c t e d  deep  i n t o  t h e  m usc le  o r  
i f  t h e  r a t e  o f  a b s o r p t i o n  i s  a c c e l e r a t e d  (by r u b b in g  t h e  s i t e )  , t h e  
p e r i o d  o f  c o n t r a c e p t i v e  e f f i c a c y  may be s h o r t e n e d  [ L i s k i n ,  1983: K -26] .
3 . 2 . 4  Implemen ting  t h e  Program
A f t e r  r e v i e w i n g  a l l  d a t a  a v a i l a b l e  and i d e n t i f y i n g  t h e  a d v a n ta g e s  
o f  DP a s  w e l l  a s  n o t i n g  t h e  s u c c e s s  o f  DP i n  T h a i l a n d  [McDanie l ,  1980: 
8 8 - 9 2 ] ,  P h i l i p p i n e s  [ E o s a r i o ,  1980: 72 -7 6 ]  and Nor th  Su la w e s i  [ B a r t e n ,  
1980: 5 2 - 5 8 ] ,  t h e  NFPCB d e c id e d  to  a c c e p t  i t  f o r  t h e  N a t i o n a l  Program i n  
l a t e  1980.
The NFPCB p o l i c y  on DP was t o  f u l l y  s u p p o r t  DP u s e r s  by o f f e r i n g  DP
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free like other methods already available. DP would account for at 
least 10 per cent of all methods available in the Program every year. 
Furthermore, the study of this drug would be continued to gain more 
experience in managing long run side effects, and more experience and 
information from other sources would be collected to develop policies on 
DP use [NFPCB, 1980: 3].
3.2.5 Procurement
Although the NFPCB had accepted DP as a method for family planning 
services in 1980, due to the difficulties of supply for mass usage, 
almost two years later, the society still could not offer it at family 
planning clinics free of charge. From commercial channels/services it 
could be purchased at Rp3000 to Rp5000 each. The problem was that the 
Program could not fund the drug nor obtain it from foreign donors such 
as USAID, who had previously given IUDs and Pills.
For the trials, in the period 1977-1979» the drugs was partly 
supplied by the Upjohn Company, now manufacturing in Jakarta, and the 
IPPF through IPPA services, with the remainder purchased by the Program 
from Upjohn. Since 1982, the Program has had government funds to buy 
DP, and has offered it widely to the entire country. The drug is now 
available both in the family planning program and through commercial 
channels.
3*2.6 Distribution and the Logistics of Depo Provera
In order to reduce dependency on foreign countries, efforts were 
directed at domestic manufacture of contraceptives, including IUDs, 
pills, condoms, and DP by stimulating private enterprise to produce 
them. Most of these modern contraceptives are now manufactured in 
Indonesia and DP is purchased by the Indonesian Government with local 
currency, which reduces logistic problems in obtaining the drug.
The distribution of DP is like that of other methods of 
contraception (IUDs, pills, condoms): from a central office or
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warehouse to provinces, regencies and municipalities and smaller units, 
and sent by professional companies hired by the Program [NFPCB, 1962: 
8^] • DP is available in the health centres and also Mobile Medical 
Teams, which visit remote areas once a month. Up to now, there have not 
been any problems concerning the storage of the drug, due to its long 
shelf life.
3.3 The Spread of Depo Provera throughout the country
The spread of DP throughout the country, can be observed from the 
monthly family planning report issued by the Bureau of Reporting and 
Recording, NFPCB. These reports show the progress of recruiting new
acceptors every month for entire provinces in Indonesia, since the 
family planning program started.
Table 3-1 shows growth in the use of DP since 1976 as well as 
changes in the use of other methods. By 1979/1980 DP was used by 2.5 
per cent, and by 1983/1984 by 24.4 per cent. Its popularity is
especially noticeable for Java and Bali. It is also noteable that when 
DP became available in 1982 the pill began to lose popularity. In 
1983/1984 the percentage of new acceptors choosing DF was close to that 
for the IUD, (see also figure 3*3)
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Table 3-1: Number of acceptors and the percentage,
Java and Bali, 1976 - 1983»
! Contraceptive methods and percent. 
Years !------------------------------------
*) ! IUB Pill Condom BP Others Total
1976/ 334,923 1,242,225 241,763 20,109 15,310 1,854,330
1977 (18.0) (67*0) (13.0 ) (1.1) (0.8) (100.0)
1977/ 307,856 1,269,979 172,330 34,219 25,772 1,810,156
1978 (17-0) (70.2) (9-5) (1-9) (1.4) (100.0)
1976/ 334,139 1,108,821 133,493 42,765 26,518 1,645,736
1979 (20.3) (67.4) (8.1) (2.6) (1.6) (100.0)
1979/ 337,590 1,169,828 129,800 42,454 31,900 1,711,572
1980 (19.7) (68.4) (7.6) (2.5) (1-9) (100.0)
1980/ 381,967 1,372,130 165,048 58,864 33,958 2,011,967
1981 (19.0) (68.2) (8.2) (2.9) (1.7) (100.0)
1981/ 447,730 1,223,881 112,963 147,243 44,984 1,976,801
1982 (22.7) (61.9) (5-7) (7.5) (2.3) (100.0)
1982/ 696,797 1,349,188 117,485 511,352 66,460 2,741,282
1983 (25-4) (49.2) (4.3) (18,7) (2.4) (100.0)
1983/ 1 ,093,919 1,575,363 98,679 918,328 85,330 3,771,619
1984 (29.0 ) (41.8) (2.6) (24.4) (2-3) (100.0)
Note: *) the financial year is calculated from first of April
up to 31 of March in the following year.
Numbers in bracket is the percentage.
Source: Calculated from NFPCB Service Statistics,
Reported at April 1984.
The new acceptors of BP rose steadily from one per cent in 1976, to 
more than ten per cent in 1983/1984* In 1983/1984, there were almost 10 
million current users, of whom, 10 per cent used BP. In this year, the 
highest percentage of BP users among new acceptors was in Vest Java 
province, 32 per cent, followed by Jakarta, 28 per cent, and Central 
Java, 23 per cent (Table 3-2, see also figure 3*4.
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Table 3 -2 :  Number o f  New Acceptors  o f  DP and the  pe rce n tage
by p ro v in c e ,  Java and B a l i ,  1976-1983*
! Bal i  !Eas t  Java!Cent JavIYogya !West Java J a k a r t a
YEARS !------------- !----------------!--------------!-------------- !----------------!------------ !
*) !Numb.Acc! Numb.Accp!Numb.Acc! Numb.Acc! Numb.Accp!Numb.Acc
1976/ 119 5050 4432 1349 5936 3223
1977 (0 .3 ) ( 0 .9 ) ( 0 .9 ) (2 .6 ) ( 1 .1 ) (2 -5 )
1977/ 516 8969 9580 2134 10174 2846
1978 (1 .2 ) ( 1 .9 ) (1 -9 ) (3 .5 ) (1 .7 ) (2 .3 )
1978/ 384 8454 13600 2164 12578 5585
1979 (1 .1 ) ( 2 .1 ) (2 .8 ) ( 4 .0 ) (2 -3 ) ( 5 .1 )
1979/ 723 6228 16252 1473 11664 6114
1980 (1 .7 ) (1-5) ( 2 .9 ) (2-9) (2-3) (5 -1 )
1980/ 779 11155 20794 2495 14327 9314
1981 (1-9) (2-5) ( 2 .8 ) (3 .8 ) ( 2 .6 ) (6 .0 )
1981/ 2015 20591 33855 4012 67462 1 9308
1982 (4-5) (4*1) (5 .2 ) ( 7 .5 ) (12 .2 ) ( i i . i )
1982/ 2884 37734 117028 4448 300425 48833
1983 (6 .1 ) (6 .2 ) (14 .2 ) ( 8 .7 ) (30 .5 ) (21 .9 )
1983/ 5419 103265 227360 5810 484352 92122
1984 (10 .7 ) (12-5) (22 .7 ) (10 .4 ) (32-1) (28 .4 )
N ote : F i s c a l  year1 c a l c u l a t e d  from the  f i r s t o f  A p r i l up to
31 o f  March i n  the fo l low ing y e a r .
Numbers in b r a c k e t a re  the  p recen tage
source :  C a lcu la ted  from NEPCB S e rv ice  S t a t i s t i c ,  
Apr i l  1984*
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3»4 Acceptability of Depo Provera, according to the results of Modular 
Surveys
The acceptability of DP by Indonesian women can be divided into; 
initial acceptance (the use of contraception), and the continuation of 
use (continuation rates) [NFPCB, 1976: 12]. Its use can be observed from 
the spread of the drug and numbers of new DP acceptors, as reported 
monthly by the Program, (in Section 3 above). The continuation rate can 
be seen from the results of the 1982 family planning Modular Surveys. 
Module 4 investigated the length of contraceptive use and reasons for 
discontinuation. The basic questionnaire obtained information in the 
following broad categories of interest: clinical record keeping
procedures, post acceptance use-effectiveness rates with a detailed 
examination of reasons for termination, and a few questions pertaining 
to Program and non-program service. Reasons for acceptance and the 
acceptors characteristics were not covered by the clinical record.
The objective of this module was to calculate the continuation 
rates, identify reasons for stopping and to assess use-effectiveness or 
avoidance of pregnancy rates. It collected information from acceptors 
who had received or used contraceptive methods between April 1, 1977 and 
March 31, 1982. Module 4 focussed on data for six provinces Java and 
Bali, as shown in Table 3-3«
As mentioned earlier, these surveys covered all methods available 
in the Program, 1977 to early 1982, when the number of DP users was 
relatively small compared to users of other methods, (1.9 per cent for 
1977/1978, 2.6 per cent for 1978/1979, 2.5 per cent for 1979/1980, 2.9 
per cent for 1980/1981 and 7*5 in 1981/1982 ). Since only 13 per cent 
of those covered in this survey were using DP, so the findings were not 
as complete as for IUDs, pills and condoms.
Table 3-3: Size of sample and respondents completing the
interview, Java and Eali, 1982.
I
Province !
1
number of 
women
! Lost to
t
! number !
follow-up ! 
 per cent* !
Eespondents 
! completed interviewI
Jakarta 2,304 845 36.7 1,464
W.Java 2,036 383 18.8 1,653
C.Java 2,303 708 30.7 1,595
7ogya 2,214 473 21 .4 1,741
E.Java 2,053 600 29.2 1,453
Bali 2,345 599 25-5 1,746
Java-Bali 13,260 3,608 27.2 9,652
Note: * percentage of number of sample 
Source: Java and Bali Family Planning Modular Surveys, 
1982, calculated from IPDP (ANU) records, 1985*
Table 3-4: Depo Provera users covered in the Survey
Province number of 
DP users
Percentage
Jakarta 325 14.0V.Java 452 22.0
C.Java 164 7.0
Yogya 346 15.6
E.Java 315 15.0
Bali 162 6.0
Java-Bali 1764 13.0
Source: Family Planning modular surveys, 1982.
Calculated from IPDP(ANU) records, 1985*
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3*4*1 Findings
Overall, the results of these surveys showed that the IUD was the 
most stable method, with high continuation rates in Java and Bali, 
followed by pills, but DP and condoms could be considered as less 
effective methods, with the lowest continuation rates. Those 
continuation rates appeared not to be influenced by the education of
users, but more affected by the motivation of users, age and parity of 
the acceptors. The older, higher parity acceptors tended to continue for 
longer periods of time, irrespective of methods used. It seems that 
regulating fertility and planning families had not yet became usual in 
1982. The "Small Size Family" norm, the NFPCB slogan, is easy to read 
but difficult to achieve.
Compared to the continuation rates for all methods, in Java and 
Bali of 66.8 per cent after 2 years and 56 per cent after 3 years, the 
continuation rates for injectables were relatively low, at 61.5 per cent 
and 45*9 per cent respectively. But the figures for every province, 
Table 3-5, show that after two years, four provinces, still had 
relatively high continuation rates Jakarta 61 , West Java 81 , Yogya 69, 
and East Java 68. These rates were close to the continuation rates for 
the IUD for Java and Bali, in the same time spans, 75*2*
Table 3-5: Continuation rates of Depo Provera by province,
Java and Eali, 1982.
Months!
of use!Jakarta.
W
Java.
C
Java. Yogya.
E
Java. Bali.
Java and 
Eali.
3 90.7 94.3 93*9 - 94.2 93*3 92.7 93*1
6 88.6 96.7 86.9 92.6 92.2 82.4 89*9
12 80.9 91*9 73*9 86.2 82.2 67.1 80.4
18 70.9 88.2 65*3 79*2 75*1 51*5 71 *7
24 61.0 80.8 48.6 66.7 68.1 41 .8 61.5
30 49*9 75*7 34.1 57*1 63*1 34*7 52.4
36 42.4 71 *3 29*1 44.7 55*8 31*9 45*9
N 325 452 164 346 315 162 1764
Source: Java and Bali FP Modular Surveys, 1982.
Calculated from IPDP (ANU) records, 1985*
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The graph (see Figure 3-0 shows that the continuation of DP at that 
time (1982) was much less than for the IUD and the pill, and 10 per cent 
less than the continuation the rates for all methods. This was probably 
because this study covered DP users who mostly obtained their services 
from "DP Trials" launched by several family planning clinics and from 
private services in big cities, while rural women had not yet been 
reached by these projects. In practice DP only became available for 
rural women in early 1982. Hence, it is easy to understand that DP users 
covered by the surveys showed relatively low continuation rates, because 
the "DP Trial" ended at the 8th injection.
Figure 3-1: Contraceptive continuation rates According to
the Results of FP Modular Survey, Java- Bali, 1982.
£c l
1 IUDs 3 DP
2 Pills 4 Condom
months i '4 iS zw Jo ^  ^
Source: Java and Bali FP Modular surveys, 1982 
Calculated from IPDP(AMU) records, 1985-
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Figure 3-2: New Acceptors By Contraceptive Methods,
Java and Bali.
Percentage
_. .Condom 
•*• Others 
--------Year
83/84 *)79/8077/7871/72
) Data in January 1984 (feedback)
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Figure 3-3: Percentage of Current Users by Contraceptive Methods,
Java and Eali.
75 ( Percentage )
50
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IUD
; '+  • -► ■ +  ■ 4 ♦  * • ♦  • - f  •
69/70
Condom 
Others 
. Year
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CHAPTER 4
INDONESIAN WOMEN AND DEPO PROVERA: 
RESULT OF THE 1985 FIELD STUDY.
4-1 Introduction
Officially, the Indonesian Family Planning Program, has included 
several brands of hormonal oral contraceptives, IUDs (Lippes loop, 
Copper, Multiload), condoms and the injectable Depo Provera. It is 
realized that for a voluntary program, a change in the contraceptive 
method must suit the demand of the user. In line with the level of 
progress of medical sciences the expansion of a Program must also be 
accompanied by upgrading because users will always require the very best 
methods.
Because of Indonesian experince with modern health facilities, 
women are accustomed to injections of many kinds of drugs. That this 
tradition prevails has been shown by the acceptance of Depo Provera. The 
advantage of this form of contraceptive lies in the simplicity of 
administration, although it is still acompanied by several disadvantages 
like the high incidence of menstrual disturbances.
The Objective
Generally, the objective of the field work reported here was to 
determine the acceptability of the modified injection schedule for Depo 
Provera based on the conditions prevailing in Indonesia. Furthermore, 
the specific objectives to be achieved in this study were:
1 . To evaluate the acceptance of DP in the large cities as well as 
in rural areas (Jakarta, Yogyakarta, and outlying areas).
2. To study the inherent effects of the method, especially the 
menstrual bleeding pattern, and to evaluate the acceptors tolerance 
towards the side effects mentioned.
3. To make recommendations, where possible, to improve the present 
motivation and services offered to DP users.
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4* To make recommendations, if possible, to change the policies in 
implementing the use of this contraceptive.
It is also hoped that this limited study will provide the 
groundwork of future studies regarding Depo Provera in Indonesia.
4.2 The Jakarta, Bandung and Yogyakarta field survey
These three cities were chosen for the study for several reasons. 
Firstly, as the population of Jakarta is ethnically the most 
heterogeneous city in Indonesia, it can be considered, in many ways, as 
a demographic and sociological laboratory. A careful study of the 
population of the city should throw light on the demographic and 
sociological future of all Indonesian [Werten, 1976: 50]. It is hoped 
that by the selection of this area the impact of ethnicity will be 
minimized. Secondly, the Central office of the Program is located in 
Jakarta, which means that the distribution system for DP would cover the
whole city and reach every clinic. Thirdly, Yogyakarta and Bandung are 
chosen as representative of the two biggest ethnic groups in Java 
(Yogyakarta represents Javanese and Eandung represents Sundanese). 
Finally, the most important reason, was the limited budget and time for 
this study which precluded inclucion of other areas.
It appears that there is not much difference between BP users in 
Jakarta, Bandung and Yogyakarta due to:
- The respondents mostly obtained the service from FP clinics which 
used the drugs supplied by the Program, produced by one company, Upjohn.
- The groups of women who have a favourable risk to benefits ratio 
for BP use can be found everywhere in Indonesia and in the three cities 
under study as well. These groups are:
1. Women who have completed their families, or those with minimum 
of 2 children (as required by the Program, see Appendix E).
2. Women who are intolerant to or have a contra-indication to use 
of pills or IUBs.
3* Women who were not bothered by cycle disturbances or prolonged 
amenorrhea.
4. Women who are liable to forget or get mixed-up about the daily 
intake of pills.
5. Couples who did not agree to use condoms or other barrier
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methods.
6. Lactating women.
- The risk- benefit of the drugs for all women in the areas under 
study were almost the same, due to the relatively small differences in 
socio-economics conditions.
- The IEC and the services provided by the Program for DP, were 
more or less the same in each place.
Therefore, the respondents are considered as equal.
4.2.1 The Respondents
Those eligible to be interviewed were DP users who were still using 
the drug at the time of interview, and those who were no longer using 
DP. The latter group were only asked the reasons why they stopped, and 
no longer considered as respondents. Those still protected by DP were 
considered as respondents if they did not refuse to be interviewed.
The eligible respondents were chosen from the list of addresses of 
DP users in clinics or hospitals which offered family planning services. 
But some addresses were also obtained from Village Contraceptive 
Distribution Centres (VCDCs) in Jakarta and Yogyakarta, and from Family 
Planning Field Workers, mainly group leaders and supervisors. These 
latter source, supplied information on users from private services.
The areas in this study were in three cities, as follows:
1. The city of Jakarta is a rapidly growing city with a population 
of nearly 6.5 million. Of this number, 94 per cent live in urban areas, 
and only 6 per cent live in rural areas [BPS, 1980: 79-80]. The people 
in Jakarta are highly mobile and tend to be in a hurry due to their jobs 
and their life style, as the tempo of life runs very fast. Its
inhabitants include many of the sub-races or ethnic groups found in
Indonesia, but most of them are from the provinces of Java,
[Ardjoboesono, 1978: 6].
Jakarta eligible respondents were chosen from 15 clinics around the 
city. Ten addresses were taken from every clinic, totalling 150. During 
field visits, 20 more addresses were selected from five VCDCs lists of 
family planning acceptors in their respective areas, which were covered 
by this study as well. From the grand total of 170 Jakarta eligible
respondents 76.5 per cent were found. Of these not all were 
interviewed, one third no longer used DP and almost 9 per cent refused
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the interview for various reasons, but still more than half completed 
the interview, (see Table 4-1).
2. Bandung is the capital of West Java province, and was the third 
biggest urban population in Indonesia, after Jakarta and Surabaya. The 
1.5 million inhabitants of Bandung are mostly from the Sundanese ethnic 
group [BPS, 1980: 5].
Bandung eligible respondents were basically selected from the list 
of FP users of "Hasan Sadikin" General Hospital. From a total sample of
35 addresses, more than three quarters were found. Of the addresses 
found, almost half were no longer protected by BP, and 1/5 did not agree 
to be interviewed. In all, only 1/3 of respondents selected completed 
the interview, ( see Table 4-1).
3. Yogyakarta, as a Special Region, has 2.8 million population. 
Of this number, less than 1/4 live in urban areas. In contrast to
Jakarta, the life style of the people is always calm and never in a 
hurry. They are mostly from the Javanese ethnic group.
In Yogyakarta, two areas were chosen, namely the municipality of 
Yogyakarta and Sleman regency. This was because, according to the Family 
Planning Service Statistics Report (Becember 1984), these areas had many 
FP acceptors using BP as their contraceptive. Overall, six clinics were 
visited three times, and on fourth occasion the writer joined the Mobile 
Medical Team and visited various areas. Nine FP acceptor groups meetings 
were attended, and door to door home visits were made (addresses gained 
from FP field workers and clinics). All clinics, Mobile Medical Teams, 
FP acceptor groups and addresses were chosen at random. From each 
clinic, 20 addresses were chosen. Other respondents were obtained by 
following the monthly activities recorded by supervisors of Family 
Planning Field Workers. Nine supervisors were chosen, four from the 
municipality of Yogya, and five from Sleman regency. The total eligible 
respondents for Yogyakarta was 150, and of these 7 per cent of addresses 
were not found. Of the addresses found, one third were no longer using 
BP, and one in every ten refused to interviewed. However, still more 
than half completed the interview ( see Table 4-1).
Of a grand total of 355 eligible respondents, 83 per cent were 
found, but only 53 per cent of respondents completed the interview, as
36 per cent no longer used BP and 10.5 per cent refused for various
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reasons to be interviewed, (see Table 4-1)• Some reasons for refusing
to be inter viewed were that they were too busy, or too embarrassed
because they wanted to keep secret that they used contraception.
Table 4-1 : Number of Eligible Respondents 
completed the Interview
and Respondents 
, DP Users
! ! Found ! Lost to interview ! Respondents
City ! No of i _ _ _ i •! completed the
!eligible ! Refused ! N L Used ! interview
!resp. ! N {%) ! H {%) ! M (%) ! N (%)
Jakarta 170 130 1 1 47 12
(100) (75.5)* (8.5)** (36.1)«f (55-4)**
Bandung 35 27 5 12 10
(100) (77.2) (18.5) (44.5) (37.0)
Yogya 150 139 15 48 76
(100) (92-7) (10.8) (34.5) (54.7)
T o t a l 355 296 31 107 158
Per cent 100 85.4 10.5 56.1 53-4
Note: *] percentage of all eligible women.
**] percentage from contacted respondents (found)
N L = no longer (use of DP)
Source: Field work study.
A small numbers of providers were also selected for interview, to 
obtain their opinions on the policies, the services, the side effects of 
the drugs and how they maintained the activities in recruiting users. 
They included doctors, midwives, and Family Planning Workers. The
doctors were the most difficult to reach, and less than half completed 
the interview, because they were too busy or they did not want to 
comment on DP. Some of them aranged for others, such as a nurse, to 
answer the questions. Finally, 60 per cent completed the interview (see 
Table 4-2)
4.2.2 Data collection
Respondents were interviewed mostly in their homes, if they 
permited it. Interviews were also held in some clinics and Mobile 
Medical posts when they respondents received their follow-up injections, 
in Yogyakarta. All interviews were recorded on cassette recorder, and
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Tab le  4 - 2 :  Samples  and R esponden ts  Completed t h e  I n t e r v i e w ,
t h e  P r o v i d e r s
C i ty
! D o c to r s
i
! Midwives ! FP Workers ! T -o t  ;a 1
! N ! F ! C ! N ! F ! C ! N ! F ! C ! N ! F ! C
J a k a r t a 4 4 1 4 4 1 4 4 4 12 12 6
Bandung 2 2 0 2 2 1 2 0 0 6 4 1
Yogya 4 4 3 4 4 4 4 4 4 12 12 11
T o ta l 10 10 4 10 10 6 10 8 8 30 28 18
P e r c e n t 100 100 40 100 100 60 100 80 80 100 93 60
Note :  N Number o f  e l i g i b l e  r e s p o n d e n t s
F C o n ta c te d  r e s p o n d e n t s
C Completed i n t e r v i e w .
S ou rc e :  F i e l d  work s t u d y  (1985)
marked w i th  t h e  r e s p o n d e n t ' s  ID numbers  o n l y ,  and n o t  t h e i r  name. Names 
were used  on ly  t o  i n i t i a l l y  l o c a t e  women i n  the  f i e l d .
The l a n g u a g e s  used f o r  i n t e r v i e w  were I n d o n e s i a n ,  Sundanese  and 
J a v a n e s e ,  de pe nd ing  on t h e  r e s p o n d e n t .  R esponden ts  who had d i f f i c u l t y  
e x p r e s s i n g  t h e i r  o p i n i o n s  i n  I n d o n e s i a n ,  cou ld  chose  be tween  J a v a n e s e
and Sundanese ( t h e  i n t e r v i e w e r  b e in g  f a m i l i a r  on ly  w i th  t h o s e  t h r e e  
l a n g u a g e s ) .  I t  s h o u ld  be p o i n t e d  o u t ,  however ,  t h a t  a t  t h e  f i r s t
m e e t i n g ,  t h e i r  own d a i l y  l a n g u a g e ,  J a v a n e s e ,  Sundanese ,  o r  I n d o n e s i a  was 
used f o r  i n i t i a l  i n t r o d u c t i o n s ,  which made th e  a tm o s p h e re  more 
c o o p e r a t i v e  and f r i e n d l y .
The t im e  f o r  i n t e r v i e w i n g  v a r i e d  from p l a c e  t o  p l a c e ,  a c c o r d i n g  to  
when r e s p o n d e n t s  were f r e e  f rom t h e  m a jo r  ho u s e h o ld  r o u t i n e s ,  e x c e p t  f o r  
the  r e s p o n d e n t s  who were i n t e r v i e w e d  a t  c l i n i c s ,  a t  t h e  Mobile  m e d ic a l  
p o s t  and t h e  a c c e p t o r s  m e e t i n g s .  " P o l i t e  r e f u s a l s "  were sometimes 
d i f f i c u l t  to  d i s c e r n ,  so t h a t  i n  some c a s e s  t h e s e  r e s p o n d e n t s  were
v i s i t e d  t h r e e  t im e s  b e f o r e  t h e i r  i n t e n t i o n  became c l e a r .  E x p e r i e n c e  i n  
Yogyakar ta  showed t h a t  i t  was g e n e r a l l y  e a s i e r  to  c o n t a c t  r e s p o n d e n t s
t h e r e ,  even though t h e  a d d r e s s e s  o f  DP u s e r s  were o b t a i n e d  m o s t l y  from 
FP f i e l d  w o r k e r s .  I t  would a p p e a r  t h a t  women i n  J a k a r t a  and Bandung, 
b e c au s e  o f  t h e i r  h i g h l y  m o b i l e  l i f e  s t y l e ,  a r e  d i f f i c u l t  t o  r e a c h .  
I n t e r v i e w i n g  took  p l a c e  d u r i n g  t h e  months o f  J a n u a r y  and F e b r u a r y  1985 
(a t o t a l  o f  50 work ing  d a y s ) .
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4.3 Results of the study
Those completing the interview were considered as respondents in 
this study, and were the main focus of investigation. Those who were 
found but were no longer using DP, were asked the reasons for 
termination.
Of those who had already stopped, 70 per cent had stopped due to 
the difficulties of obtaining follow-up injections, almost 10 per cent 
wanted more children, and only 11 percent had stopped because of side 
effects. Other reasons for stopping (such as menopause, divorcee, or 
teporary separation from husband for six months or more) were grouped as 
"Others", (see Table 4-3«)
Table 4-3: Reasons for Termination
City
! no of ! 
!Respon-! 
!dents !
R e a s o n s
A ! B ! C ! D ! E !
Jakarta 47
(100)
36
(76.6)
5
(10.6) (4.23)
1
(2.1) (6?4)
Bandung 12
(100)
7
(58.3) (8.3)
2
(16.7) (8.3) (8.3)
Yogya 48
(100)
32
(66.7)
4
(8.3)
4
(8.3)
2
(4.2)
6
(12.5)
T o t a l 107 75 10 8 4 10
Per cent 100.0 70.0 9-4 7.5 3-7 9.4
Note: (••) percentage
A difficult to find follow up injection
B want another child
C Amenorrhoea 
D Bleeding 
E Others
Source: Field work study (1985)
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4.5*1 Number o f  i n j e c t i o n s
As m ent ioned  e a r l i e r ,  t h i s  s t u d y  covered  158 f em ale  r e s p o n d e n t s ,  
p r o t e c t e d  from p regna nc y  by DP. The l e n g t h  o f  u se  ranged  from u s e r s  who 
had j u s t  r e c e i v e d  t h e i r  f i r s t  i n j e c t i o n ,  up to  t h o s e  w i th  more t h a n  15 
i n j e c t i o n s ,  a s  shown i n  Tab le  4-4 be low.
From t h i s  t a b l e  i t  can be s e en  t h a t  5 /4  o f  r e s p o n d e n t s  had been 
u s in g  DP more t h a n  one y e a r .  They can be g rouped  a s  h i g h l y  m o t i v a t e d  
u s e r s ,  and can be c o n s i d e r e d  a s  " s t a b l e  u s e r s " .
Tab le  4 - 4 :  Number o f  DP i n j e c t i o n s ,
a c c o r d i n g  t o  t h e  l e n g t h  o f  u se  a t  i n t e r v i e w
The l e n g t h  i n  
use
! Number o f  
! Responden ts
! Pe r  c e n t
I
1 — 5 rd i n j e c t i o n s 41 2 5 .9
4 — 8 t h  i n j e c t i o n s 47 29 .7
9 -  12th i n j e c t i o n s 55 22 .2
15th and more 55 22 .2
T o t a l 158 1C0.0
Source :  F i e l d  work s t u d y  (1985)
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4*5«2 The Sources o f  In fo rm at ion  on Depo Provera
The main source  of  in f o r m a t io n  on DP f o r  more than h a l f  the  
r e s p o n d en ts  was Health  Workers,  w hile  Family Planning  Workers,  who 
should p lay  the  most im p o r tan t  r o l e ,  only informed one q u a r t e r  of  the  
r e s p o n d e n t s .  Less than one i n  every  t e n  u s e r s  gained  t h e i r  in fo rm a t io n  
from the mass media.
Table 4 -5 :  The P e s p o n d e n t ' s  Source o f  In fo rm at ion  about  DP
No. S o u rc e s . Number o f  
Respondents.
Per  cen t
1. FP Workers 59 24.7
2. Hea lth  Workers 81 51.5
5. V i l l a g e  Head 7 4.4
4. Family/  E e l a t i v e 12 7 .6
5. Mass Medias 15 8.2
6. Others 6 5 .8
T o t a l 158 100.0
Source:  F ie ld  Work Study (1985)
Eelow a re  a few comments from responden ts  about  t h e i r  source  of  
i n f o r m a t i o n :
I go t  in fo rm a t io n  on EP a f t e r  I c o n s u l t e d  a d o c t o r .  He 
sugges ted  t h a t  method f o r  me, and I t r i e d .  I kep t  u s ing  i t  
u n t i l  now, and t h i s  one i s  the  method I l i k e  very  much. A few 
t ime F ie ld  Workers (PLKB) v i s i t e d  our house,  bu t  th ey  only 
pushed us to use IUDs. As Moslem women we a r e  not  al lowed to 
show our g e n i t a l  o rgans ,  excep t  in  an emergency.  Most Moslems 
did no t  a c c e p t  IUDs f o r  t h a t  r e a s o n s .  Using a c o n t r a c e p t i v e  i s  
no t  an emergency,  we s t i l l  have many a l t e r n a t i v e s " .
Eefore I  jo in e d  the " T r i a l  P r o j e c t "  I had never  heard  of  
DP. I got  some in fo rm a t io n  from the  newspaper,  bu t  mos tly  they 
only d i scu ssed  c a n c e r .  The good in f o rm a t io n  I go t  was from the 
d o c to r  who o f f e r e d  DP on the  t r i a l  p r o j e c t .  This method s u i t e d  
me, so I con t inued  to use i t .  Up to now, DP has p r o t e c t e d  me 
f o r  almost  4 1/2 y e a r s " .
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4*3*5 The Cost
In this study, the cost is considered from both sides, from that of 
DP users and that of the Program side. For DP users, the cost is what 
they have to pay to get the service, and this ranges from nothing to 
Rp7000 per service. All contraceptives available in the Program were 
distributed free to every FP clinic, and it was hoped that it would be 
distributed to users free. Eut at the service points (hospitals, and 
health centres) people who asked for any service including DP users had
to pay a small amount of money for administrative purposes. This kind of 
payment varied from one clinic to another, and from one city to another, 
from Ep150 to Rp499» The Program did not consider this kind of payment 
as the cost of the drug. Therefore, from the point of view of the 
Program, the costs of DP can be grouped into: payments from zero to 
Rp499 which were considered as free of charge; and from Rp500 to Rp7000, 
considered as the charge of the drug, for services both from government 
and private outlets. Although the services took place in hospitals or in 
health centres, if the drug used was not from a Program source, it was 
considered as a private service. The problem was, not every person knew 
which drug they used. They only knew that for family planning purposes 
they may get free services from government hospitals and health centers. 
Where some people had to pay but others did not, those who paid got 
angry with the Program, and blamed the Family Planning Program, not the 
service point.
According to the study, almost half the users gained their DP 
services "free". In addition, some users reported that the first and 
second injection was free frcm> the clinic but from the third injection 
onward they had to pay Rp2000, although they received the service in the 
same place as before (see Table 4-6.)
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Tab le 4 - 6 : The Cost o f  Depo P rove ra
C o
1
i
s t  !
S e r  v 
Government  !
i c e s
P r i v a t e
!
! T o t  a 1
i _
! KI.M.T ! C l i n i c s ! DR ! MW
and
! (Pe r  c e n t )
Rp 0. -  RP 0. 6 30 - - 36 (22 .8 )
Rp50. -  Rp499. - 39 - - 39 ( 2 4 .7 )
Rp500. -  Rp999- - 9 - - 9 ( 5 . 7 )
RP1000. -  Rp1999* - 14 - 8 22 ( 15 -9 )
Rp2000. -  Rp4999* - 26* 21 4 51 (52-5)
Rp5000. -  and + - - 1 - 1 ( 0 . 6 )
T o t  a 1 5 118 22 12 158 ( 100 .0 )
N o t e : M.M.T = Mobile Medica l Team
DR = D o c to r s
MW = Midwives
*)  They r e c e i v e d  t h e  i n j e c t i o n  b e f o r e  t h e  Program
adopted  DP, and s t i l l  p a id  t h a t  amount up to  t h e
t ime o f  i n t e r v i e w .
S ou rc e :  F i e l d  work s t u d y  (1985)
" I  r e c e i v e d  a DP i n j e c t i o n  w h i l e  I  gave  b r e a s t m i l k  to  my 
baby .  S inc e  t h e  t h i r d  i n j e c t i o n  I  have  had t o  pay Rp2000 each 
i n j e c t i o n .  The midwife  a lw ays  s a y s  "no more DP s t o c k s  from t h e  
t h e  Program, so i f  you need i t ,  you have  t o  p a y " .
Some u s e r s  a l s o  r e p o r t e d  t h a t  t h e y  had p a id  f o r  t h e i r  i n j e c t i o n  
s i n c e  t h e y  began u s i n g  i t .  They s t a r t e d  b e f o r e  t h e  Program d i s t r i b u t e d  
DP i n  1980 when i t  was n o t  a v a i l a b l e  i n  t h e  Program, b u t  t h e y  r e c e i v e d  
t h e  s e r v i c e  from t h e  c l i n i c  which c u r r e n t l y  a l s o  g i v e s  f r e e  s e r v i c e s  to  
new DP u s e r s .  For  t h e  " o ld "  u s e r s ,  t h e  " o ld  game" i s  s t i l l  go in g  on.
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"I have used DP since 1980 up to now, and the cost of each 
injection has ranged from Rp3000 to Rp5000. Recently I saw that 
the Health Centre (where I got the service) offered DP to new 
users free of charge. I asked, why do I have to pay, while 
another users do not. The answer was, You were the old users, 
you already used DP before we got the drugs from the Program.
Up to now you were using the drugs from private channels, so you 
have to pay. I would move to another health centre for the next
injection, and I would tell them that I am the new user".
Other users explained that they have to pay after the eighth 
injection. These users were involved in the DP trial project launched 
in 1980 until 1982 (eight injections). When the project was over, the 
users had to pay as they then received the service from a private 
doctor.
"Last month should have been my fifteenth injection, but I 
did not take it. I did not have enough money to pay for the 
drug. This has happened a few times, since free injections have 
finished. Starting from the ninth injection, I have to pay 
Rp3C00 each" .
4.3.4 The Source of Depo Provera Service
Before the Program distributed DP throughout the country, DP were 
already available in private services from doctors and midwives, who 
obtained the drug from commercial channels, users had to pay for 
services from these channels. This study found that 118 respondents, or 
3/4, gained their first service from FP clinics, while 14 per cent and 
12 per cent respectively obtained their first service from private 
doctors and private midwives (see Table 4-7)*
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Tab le  4 - 7 :  The Source  o f  F i r s t  and L a s t  DP S e r v i c e s
f o r  t h e  Responden ts
No. P l a c e  o f  S e r v i c e s . Number o f  R e s p o n d e n t s .
F i r s t  s e r v i c e L a s t  s e r v i c e
Program S ou rc es
1. FP. C l i n i c s 118 128
( 7 4 . 7 ) ( 8 1 .0 )
2. Mobil  Medica l  Teams 6 8
( 3 -6 ) ( 5 - 1 )
P r i v a t e  Sou rces
3* P r i v a t e  D oc to rs 22 10
( 1 3 . 9 ) ( 6 . 3 )
4.  P r i v a t e  Midwives 12 12
( 7 . 6 ) ( 7 . 6 )
T o t a l 158 158
(100 .0 ) (100.0)
Note: ( . . )  p e r c e n t a g e .
S ou rc e :  F i e l d  -work s t u d y  (1985)
Four  f i f t h s  o f  r e s p o n d e n t s  r e c e i v e d  t h e  f o l l o w - u p  from FP c l i n i c s ,  
l e s s  t h a n  1 /10  from p r i v a t e  d o c t o r s  and p r i v a t e  midwives ,  and 5 p e r  c e n t  
from m ob i le  m e d i c a l  team (Tab le  4 - 7 ) .
Some r e s p o n d e n t s  s a i d  t h a t  t h e y  moved from p r i v a t e  s e r v i c e s  t o  the  
h e a l t h  c e n t r e  a f t e r  t h e y  h e a r d  o r  saw t h a t  DP was o f f e r e d  t h e r e .  The 
r e a s o n  was t h a t  t h e y  co u ld  have t h e  same s e r v i c e  f o r  a low e r  p r i c e  o r  
t o t a l l y  f r e e .
" P r e v i o u s l y  I  r e c e i v e d  DP i n j e c t i o n s  from a p r i v a t e  d o c t o r .  
I t  c o s t  me 7000 r u p i a h  e a c h .  Three months ago I  h e a rd  t h a t  t h e  
Program o f f e r e d  DP a t  no c h a r g e  i n  t h e  H e a l t h  C e n t r e s ,  so I 
moved i n  t o  Puskesmas .  I was r e a l l y  happy ,  b e s i d e s  t h e  s e r v i c e  
i s  n o t  so d i f f e r e n t  from a p r i v a t e  d o c t o r ,  i t  s a v e s  a l o t  o f  
money".
56
4.5*5 Reasons  f o r  c h o o s in g  Repo P r o v e r a
From Table  4 -8  be low,  i t  i s  a p p a r e n t  t h a t  ove r  t h r e e - q u a r t e r s  o f  
r e s p o n d e n t s  chose  RP a s  t h e i r  c o n t r a c e p t i o n  f o r  r e a s o n s  such  as  " I  l i k e  
i t ,  b e c au s e  i t  i s  p r a c t i c a l " .  I t  can be assumed t h a t  t h e y  were f u l l y  
aware t h a t  RP was t h e  b e s t  c o n t r a c e p t i v e  f o r  them a f t e r  compar ing  i t  to  
o t h e r s .
Table  4 - 8 :  The Reasons f o r  Choosing Repo P ro v e ra
No
1
! R e a s o n s
!
! Number o f  
! R esponden ts
! Pe r  c e n t
1
1. I  l i k e  i t ,  p r a c t i c a l 125 7 7 . 8
2. I  ca n n o t  u se  o t h e r s 9 5-7
5. Sugges ted  by some one 22 12 .9
4. O the rs 4 2 .5
T o t a l 158 100.0
Source :  F i e l d  work s t u d y  (1585)
The u s e r s  i n  t h i s  s t u d y ,  however ,  chose  RP m o s t l y  a f t e r  t h e y  had 
e x p e r i e n c e  w i th  o t h e r  methods such  a s  IURs, p i l l s  and condoms. From 
Table  4 - 9 ,  i t  a l s o  can be se en  t h a t  a lm o s t  t h r e e - q u a r t e r s  o f  r e s p o n d e n t s  
chose RP a f t e r  u s i n g  a n o t h e r  method.  RP was t h e  second method f o r  58 
p e r  c e n t ,  and t h e  t h i r d  method f o r  14 p e r  c e n t  o f  r e s p o n d e n t s .
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Table 4-9: Methods use before using DP
Number ! Last Methods Used Before DP ! T o t a 1
of !---------------------------------------------------
Methods ! None IUDs Pills Condoms Others Eesp. % 
Use ! Use
No
Other ! 45j 0 0 0 0 45 28.5
One
Other
!
! 0 i 25 38 26 2 91 57.6
Two
Others
1
! 0 5 13 4 0 22 13.9
Total ! 45 50 51 30 2 158 100.0
% ! 26.5 19.0 32.3 19.0 1.3 100.0
Source: Field work study (1965)
"I never used any contraception before. After I delivered my 
third son, the doctor suggested I have an injection 
contraceptive because I was nursing my child".
"I live with mother and father-in-law, they want me to have 
five children. After my third child, I began to consider having 
a rest for a few years. The best method I could chose without 
the knowledge of my family was DP. Today I will have my fifth 
injection. I am quite happy with DP. So far, I have not 
suffered any side effects, and my family still does not know 
about it". (we met her in a health centre)
"After I had discussed it several time with my husband, at 
last we chose DP. A lot of neighbours in this block (Armed 
Forces housing blocks) use DP. So I tried it after a long 
discussion with a doctor. -For almost 6 months, I suffered 
irregular menstruations, but since the fourth injection, I have 
lost my cycle completely. My husband and I are very happy with 
that situation".
"I used an IUD following the birth of my first child. Three 
months later I had heavy bleeding, so I moved to pills. I 
passed one year safe and sound, but after that, sometimes I
forgot to swallow the pills, and this is the"result"(she pointed 
to a 3 years old boy). I have received injections since this 
boy was one month old".
It seems that DP was already popular in the areas under study. 
Eespondents said that they were happy with DP because it had more 
advantages than other methods. That almost three-quarters had used DP
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after trying one other method or two other methods, indicated that DP 
was used by respondents after they had compared it to other methods, and 
reached the decision that DP was the preferred method for them. As 
remarked by Robert A.Hatcher [1978: 215] "DP has its own population".
Furthermore, the comments from the women indicated that the 
availability of DP services in the Rational Program at least filled the 
gaps left by other methods, and gave strong support to the Program's 
achievements. As Potts [1978: 9] observed, more methods available means 
more choices, and more people will join the program.
4.5*6 Depo Provera and Nursing mothers.
This study also tried to collect respondents opinions about the 
effects of DP on breastmilk. Although those opinions came from mothers 
with no medical background, their responses can be viewed as one of the 
"push" factors encouraging use of DP.
Of 158 DP users covered by this study, three-quarters breastfed 
their babies while using DP. More than half said that the breastmilk was 
as usual", meaning that the volume of breast milk was the same as 
before they used DP. One fifth of mothers said that their breastmilk was 
better than the previously when they did not use any contraception. The 
rest could not gave any opinions about it, because they did not remember 
or they did not notice, and no one reported adversely (see Table 4-10).
Table 4-10: Respondents who Breastfed and Their
Opinions about the effect of BP on Breastmilk.
No. Lactating mothers. Respodentts. Per cent.
1 . Yes 118 74.7
2. No 40 25-3
T o t a l 158 100.0
Mother's Opinions
No. Opinions. Number of mothers . Per cent
1 . As usual 70 59.3
2. Better 26 22.0
3. Bo not Know 22 18.6
T o t a l 118 100.0
Source: Field work study (1985)
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4«3»7 Regularity of Taking Follow-Up Injections.
Because a dose of 150 mg of DP is injected intramuscularly every 
three months, users have to take follow-up injections four times a year 
to keep a safe level of protection from pregnancy. All users get this 
information clearly before they use DP for the first time. Table 4-12 
shows that almost 2/3 of the respondents did not follow a regular
schedule in taking their follow-up injections. More than half were 1 to 
2 weeks late, and 12 were 3 to 4 weeks late. The main reasons for this 
was not laziness or shortage of drugs in clinics, but rather lack of 
money to purchase DP or pay the service fee. If the date for follow-up 
came, and at that time they did not have money, they postponed the 
injection until they had enough money. Being highly motivated in 
planning their families, those that postponed were fully aware that if 
they did not use any method during the "empty" (unprotected) period, 
there was a chance that they would get pregnant. To avoid unwanted 
pregnancy they used other methods: one-third of respondents used
condoms, more than one-fourth used pills, and another one-fourth avoided 
having intercourse. Only a little more than one-tenth of respondents did 
not use anything to protect themselves from pregnancy. Table 4-1 1 has 
details of the substitute methods used.
"I have used DP for 3 years. The first year I paid Rp3000, 
then Rp4000, and now, I have to pay RP5500. When the date to 
take the follow-up came and I did not have money, I would asked 
for pills. I took the pills .regularly until I had enough money 
for another injection."
"I have used DP for four years. some times I did not take 
the follow-up regularly. I was not lazy or forgetful, but the 
main problem was I could not afford Rp5000 at that time. When 
this happened, it means that we (respondent and her husband) had 
to use separate bedrooms, and I locked my bedroom door at night"
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Tab le  4 - 1 1 :  The R e g u l a r i t y  o f  Fol low-Up I n j e c t i o n s ,
and S u b s t i t u t e  Methods Used
No Taking F o l low ­
up
Number o f
Respon­
d e n t s
! S u b s t i t u t e Methods
P i l l s . Condoms . Avoid 
i n t r c .
N o th in g .
1. La te  1 -  2 Weeks 80 23 29 19 9
2. La te  3 - 4  Weeks 12 3 2 4 3
Sub T o t a l 92 26 31 23 12
3. Never Late 66 — — — —
T o t a l 158
Source :  F i e l d  work s t u d y
4 .3 * 8  The O b j e c t i v e s  i n  u s i n g  Depo P rove ra
As men t io ned  i n  S e c t i o n  3»4, t h e  o b j e c t i v e s  f o r  u s i n g  c o n t r a c e p t i o n  
can be c a t e g o r i z e d  a s  s p a c i n g  and s t o p p i n g  c h i l d  b e a r i n g .  Tab le  4-12 
shows t h a t  more th a n  h a l f  t h e  r e s p o n d e n t s  i n  t h i s  s t u d y  used  DP f o r  
s p a c i n g ,  and 41 p e r  c e n t  f o r  s t o p p i n g .  F u r th e r m o r e ,  t h e  Table  a l s o  
shows t h a t  r e s p o n d e n t s  who a l r e a d y  had 3 o r  more c h i l d r e n  a r e  more 
l i k e l y  t o  s t o p ,  and t h e  more c h i l d r e n  t h e y  have t h e  more t h e y  want  t o  
s t o p .  R esponden ts  d e s i r i n g  to  s p a c e  f a m i l i e s ,  showed t h e  r e v e r s e d  
p a t t e r n .  In  a d d i t i o n ,  a s  s t a t e d  i n  C h a p te r  I I I ,  i n  I n d o n e s i a  DP i s  on ly  
a v a i l a b l e  f rom o f f i c i a l  o u t l e t s  f o r  women w i th  2 c h i l d r e n  and more,  so 
no r e s p o n d e n t s  had no c h i  . I r e n  a t  a l l .  In  Tab le  4 -1 2  t h e  few 
r e s p o n d e n t s  w i th  one c h i l d  p r o b a b l y  o b t a i n e d  th e  s e r v i c e  from p r i v a t e
c h a n n e l s .
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Table 4-12: The Objectives of 
according
using Depo 
to Parity
Provera
Parity
! Stop. Space. F.Welfare. D. Know. T o t a 1.
! % % % % % N
0 0.0 0.0 0.0 0.0 0.0 0
1 33*3 66.7 0.0 0.0 100.0 6
2 16.7 56.2 18.8 6.3 100.0 16
3 27.9 65*1 4.7 2.3 100.0 43
4 42.9 57*1 0.0 0.0 100.0 35
5 + 61.4 38.6 0.0 0.0 100.0 44
N.A 35*7 57.2 0.0 7.1 100.0 14
Note: N.A = No Answer/ Not stated.
F. welfare= family welfare 
D.know = do not know 
Source: Field work study (1985)»
4*3*9 The Side Effects of Fepo Provera
Most women experienced some menstrual cycle disruptions, including 
lost of cycle (amenorrhoea), irregular bleeding and spotting or change 
in frequency, duration, and amount of blood loss. Table 4-13 shows these 
four types of menstrual disruption were suffered by four-fifths of the 
respondents, with almost half experiencing amenorrhoea, almost one-tenth 
spotting, and one-fifth suffering irregular menses. Only a few had heavy 
menses.
"This respondent used DP for almost 4 years (16 injections). 
She told us that the first 5 months after receiving DP 
injections was the "hard" period for her. She suffered 
headache, irregular menstruation and two months spotting. After 
the third injection, everything improved, no more headache and 
no spotting. After the 8th month of injections she lost her 
cycle (amenorrhoea). She was not afraid, she asked for a 
pregnancy test every three months (before she had another 
follow-up). If she wanted her cycle back, she was told it was 
easy, just stop injections and use pill contraception instead.
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Table 4-13: The Length of Use and Side Effects Experienced.
Duration! S I D E  E F F E C T S  ! !Per
in !------------------------------------- ! Total! cent
Use !Ame- !Spot!Heavy!Irr.!Incr. !Head!Ner-!Oth! !
!norr-!ting!mens.!mens!weight!ache!vous!ers! !
! hea ! ;i 1 !ness! ! I
1 — 3rd 17 7 - 10 2 3 2 41 25*9
4— 8th 23 4 1 12 6 - 1 47 29.7
9-12th 16 - 3 8 7 - 1 35 22.2
13— up 18 3 1 5 7 - 1 35 22.2
Total 74 14 5 35 22 3 1 4 158 100.0
Per cent 46.8 8.9 3*2 22.2 13*9 1.9 0.6 2.5 — 100.0
Source: Field work study(l985)
When the regular cycle became normal again, then she went back 
to injection. She and her husband were quite happy with DP".
4*3*10 Tolerance to Side Effects
To determine the tolerance of users to side effects, the study 
solicited information from providers, especially doctors and midwives, 
as well as from DP users themselves. As pointed out above (Table 4-13) 
the most important side effect was menstrual disturbance. But why did 
they continue to use DP if there were side effects? More than half the 
respondents had used DP for more than two years. one doctor from a 
health centre in Yogyakarta said:
"Surprisingly enough, if properly managed, the disordered 
bleeding (spotting, heavy menstrual periods, and irregular 
menstrual periods) was well accepted by women who have been 
adequately prepared for it in advance. Here (the health centre)
we have almost 1000 DP users (985 users), who never drop out 
except if they want more children".
The explanation reported by many providers was that spotting was 
considered as normal menstruation, and it did not bother users. It 
occurred only for a few months, and was replaced by amenorrhea, and
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heavy menstrual bleeding did not occur every month. Only 5 respondents 
(5 per cent) experienced heavy bleeding, and if they reported these side 
effects to clinics, they were treated properly. One doctor from a health 
centre in Jakarta reported:
"For heavy bleeding, we give them an extra DP injection to 
control the bleeding, two weeks after the first (previous) 
injection, and several tablets before it. This extra injection 
of DP is to hasten the atrophy of the endometrium, and will then 
produce amenorrhea."
The users also gave reasons why they accepted DP in spite of its 
disadvantages:
"For me, as a farmer's wife with a hard life and hard work 
every day, I prefer DP. Two years ago I used an IUD, but as you 
know, the IUD is not suitable for hard working women. Besides 
that I feel very shy when I have to take follow up control. 
Since I received injections (2.5 years ago) I feel more healthy, 
and I can pray every day without being bothered by my cycles", 
(Moslem women have to postpone their religious activities when 
they are menstruating, and the activities which were postponed 
must be done later beside the daily religious tasks).
Irregular menstruation means changes in the menstrual pattern, and 
times when the cycle is unpredictable. For these side effects, a doctor 
explained:
"They get extra oral pills, which they have to use until 
their menstrual patterns is normal again. Most women still 
pointed out that the advantages of complete protection for a 
three month interval may outweigh the apparent inconvenience of 
using both oral medication and injection. Furthermore, the 
women who failed to take their oral supplement do not increased 
the risk of pregnancy as does the women who failed to take an 
oral contraceptive tablet".
While amenorrhoea, which was experienced by almost half the 
respondents, may cause some women concern, reduced blood loss might have 
the beneficial effect of reducing the chances of developing anaemia. 
Undernourished women will benefit from amenorrhoea [Cautinho, 1978: 79]»
"I believed to my doctor, although I lost my cycle for almost 
1.5 years. If the doctor still says okay, I will continue to 
use DP, because my body does not feel peculiar but feels 
normal" .
Most of the respondents in this study were Moslems, and the Moslem 
women were not distressed by amenorrhoea. They were not interupted in
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t h e i r  d a i l y  p r a y e r s ,  f a s t i n g  i n  t h e  f a s t i n g  month,  h a j  p i l g r i m a g e  o r  
o t h e r  r e l i g i o u s  a c t i v i t i e s .  Kost  husb a n d s  were a l s o  happy w i th  t h o s e  
c o n d i t i o n s ,  b e c a u s e  t h e y  co u ld  have  sex  whenever  t h e y  w i s h e d .  As Moslem 
women a r e  p r o h i b i t e d  from sex  d u r i n g  m e n s t r u a l  c y c l e s ,  husband gave 
s t r o n g  s u p p o r t  t o  u s i n g  DP c o n t i n u o u s l y .
C au t inho  [ 1978: 80]  n o t e d  t h a t  m e n s t r u a t i o n  was n o t  s e en  by women 
as  som e th ing  d e s i r a b l e .  I f  t h e y  d id  n o t  have  t o  b l e e d  w h i l e  r e m a in i n g  
h e a l t h y ,  i t  was l i k e  b e in g  p r e g n a n t  w i t h o u t  a baby ,  and t h e y  were happy 
with t h e  c o n c e p t  o f  am e n o r rh o e a .
I n c r e a s e d  w e ig h t  was c o n s i d e r e d  by most women who s u f f e r e d  i t  no t  
to  be one o f  t h e  s i d e  e f f e c t s  o f  DP. They were happy w i th  w e i g h t  g a i n ,  
because  i t  was viewed a s  h e a l t h y .
As m en t ioned  above ,  a l l  t h e  a d v a n t a g e s  may ou tweigh  t h e  a p p a r e n t  
i n c o n v e n i e n c e  o f  u s i n g  DP, o r  i n  o t h e r  w ords ,  t h e  r e s p o n d e n t s  were 
h i g h l y  t o l e r a n t  o f  t h e  s i d e  e f f e c t s ,  b e c a u s e  o f  t h e  p e r c e i v e d  
a d v a n t a g e s .  Prom Tab le  4 - 1 4 ,  i t  can be s e en  t h a t  most  women i n  t h i s  
s t u d y  s t i l l  wanted t o  c o n t i n u e  t o  use  DP f o r  s e v e r a l  months ,  and a lm os t  
2 /3  o f  r e s p o n d e n t s  would c o n t i n u e  f o r  25 months and more.
Ta b le  4 - 1 4 :  I n t e n t i o n  t o  Con t inue  DP use  a c c o r d i n g  to
r e p o r t e d  S ide  E f f e c t s
! S I D E  E F F E C T S .  ! !
C o n t in u e ------------------------------------------------------------------------------- ! T o t a l ! Pe r
t i l l  !Arne-!S p o t !h e a v y ! I r r e - ! I n c r e !Head! H e r - !O t h e r ! ! c e n t
!n o r r ! t i n g l m e n s . I g u l a r ! a s e  ! a c h e ! v o u s !  ! !
Ihoea 1 I Im ens . !w e i g h t • ! n e s s ! 1 ! ;
0 — 6mts 11 3 1 2 2 1 - - 20 1 2 .7
7 — 12mts 4 3 - 2 - - 1 1 11 7 . 0
1 3 - 1 8mts 10 - 1 2 - - - - 13 8 . 2
19 - 2 4 m t s 9 - - 8 1 - - 1 19 1 2 . 0
25 and + 40 8 3 21 19 2 - 2 95 60 .1
T o t a l 74 14 5 35 22 3 1 4 158 1 0 0 . 0
P e r  c e n t
COVO 8 . 9 3 . 2 2 2 . 2 1 3 . 9 1 . 9 0 . 6 2 . 5 1 0 0 . 0
S ource :  F i e l d  work s t u d y  (1985)
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4.3*11 The Continuation of use
The continuation of use of DP in this study was apparently very 
high, as can be observed from Tables 4-13, 4-14 and 4-15* Table 4-13 
shows that 74 per cent had used DP for one year and more and 44 per cent 
for more than two years.
Table 4-15 shows that three-fifths of the respondents wanted to 
continue to use DP for 25 months and more. More than half of these had 
already had 9 or more injections, which means they already had used DP 
for 2-3 years and they still wanted to continue for at least two years 
more. Although, this was not the perfect measurement to evaluate the 
continuation rate of DP, at least it proved the high popularity and 
acceptability and respondents preference in contraceptive methods. It is 
safe to say, however, that DP gained its own " followers" from the other 
methods available.
Table 4-15: The Intention to Continue to use DP
According to the duration of Use
Duration of ! 
use !
(number of ! 
injections)!
Intention to Continue i
!T o t a 1 
1 
t0 - 6months
7-12
months
13-18
months
1 9 - 2 4
months
25 and + 
months
1 - 3 rd 8 5 3 7 18 41
4 - 8 th 4 4 7 3 29 47
9 - 12 th 4 1 2 4 24 35
13 and + 4 1 1 5 24 35
T o t a l 20 11 13 19 95 158
Per cent 12.7 7.0 8.2 12.0 60.1 100
Source: Field work study (1985)
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4-4 D i s c u s s i o n
Every Family  P l a n n in g  Program has  two i m p o r t a n t  t o o l s ,  t h e  
I n f o r m a t i o n ,  E d u c a t i o n ,  and Communication (IEC) and t h e  c l i n i c a l  and 
o u t r e a c h  s e r v i c e s .  The IEC g e n e r a t e s  t h e  demand f o r  c o n t r a c e p t i v e s  and 
t h e  s e r v i c e s  mee t  t h a t  demand. O b v io u s ly ,  t h e s e  v e r y  i m p o r t a n t  t o o l s  
i n f l u e n c e  t h e  p o p u l a r i t y  and t h e  a c c e p t a b i l i t y  o f  e v e r y  method a v a i l a b l e
i n  t h e  Program. In  t h e  a r e a s  u n d e r  s t u d y ,  t h e s e  mechanisms s i g n i f i c a n t l y  
p layed  a s p e c i a l  r o l e  i n  t h e  p e r f o r m a n c e  o f  DP. As a l r e a d y  m e n t io n e d ,  DP 
was t h e  new es t  c o n t r a c e p t i v e  i n c o r p o r a t e d  i n t o  t h e  I n d o n e s i a n  FP 
Program. Hea ted  d e b a t e  f o l l o w e d  i t s  r e j e c t i o n  by t h e  FDA i n  1978, and 
t h i s  news made DP u n p o p u l a r  i n  I n d o n e s i a  f o r  a few y e a r s  a round  1980, 
e s p e c i a l l y  to  women i n  t h e  u p p e r  and m idd le  c l a s s e s .  The s i t u a t i o n  
became w orse ,  b e c a u s e  t h e  Program d id  n o t  p r o v i d e  enough i n f o r m a t i o n  and 
did n o t  promote t h i s  d rug  i n t e n s i v e l y .  That  i s  why, u n t i l  r e c e n t  y e a r s ,  
on ly  a few women knew t h a t  t h i s  k ind  o f  i n j e c t a b l e  c o n t r a c e p t i v e  was 
a l r e a d y  a v a i l a b l e  i n  t h e  Program. Th is  phenomenon can be d e t e c t e d  from 
Table  4 -5  and t h e  i s s u e s  d i s c u s s e d  i n  some new spape rs  i n  I n d o n e s i a  :
"We a r e  f a m i l i a r  w i t h  t h e  c o n t r a c e p t i v e s  which a r e  a v a i l a b l e  
i n  t h e  Program such  a s  IUDs, p i l l s ,  and condoms. But c u r r e n t l y  
I  h e a rd  t h a t  t h o s e  who f a i l e d  w i t h  t h e s e  c o n t r a c e p t i v e s  may 
o b t a i n  an " i n j e c t i o n " .  I s  t h a t  " i n j e c t i o n "  a new k ind  o f  
c o n t r a c e p t i v e  method ? " .  [ P e l i t a , 2 8 / 2 /1 9 8 1 :  4]
The l a c k  o f  i n f o r m a t i o n  n o t  on ly  a f f e c t e d  o r d i n a r y  women who had 
n e v e r  used any c o n t r a c e p t i v e ,  b u t  a l s o  t h e  u s e r s  t h e m s e lv e s  d id  no t  g e t  
p r o p e r  i n f o r m a t i o n .  The q u e s t i o n  below a p p e a r e d  i n  Posko ta  Minggu, which 
i s  t h e  p o p u l a r  newspaper  i n  t h e  C a p i t a l  o f  J a k a r t a :
" I  have  used t h e  i n j e c t a b l e  c o n t r a c e p t i v e  Depo P r o v e ra  f o r  6 
y e a r s .  I  was 59 y e a r s  o l d ,  when I had to  s t o p  t h i s  
c o n t r a c e p t i v e .  I s  i t  t r u e  t h a t  DP u s e r s  become i n f e r t i l e ?  I 
w o r r i e d  so much b e c a u s e  I  t o t a l l y  l o s t  my c y c l e s  i n  t h e  l a s t  two 
m on ths" .  [ Posko ta  Minggu, 2 4 / 5 /1 9 8 1 :  10] .
A f t e r  s e v e r a l  s e m i n a r s  and f i e l d  t r i a l s ,  t h e  MFPCB s t a r t e d  to  
d i s t r i b u t e  t h e  d rug  w i d e ly  i n  1982. However, t h e  m o t i v a t i o n  and 
p romot ion  s t i l l  l ag g e d  f a r  b e h in d  t h a t  f o r  o t h e r  m e thods ,  p r o b a b l y  
b e c au s e  t h e  p r o v i d e r s  were s t i l l  a f f r a i d  o f  s u s p e c t e d  s i d e  e f f e c t s  and 
l i m i t e d  s t o c k s  o f  t h e  d r u g .  The community as  t h e  t a r g e t  o f  I n f o r m a t i o n ,
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Education, and Communication (IEC), still received much less of the 
basic information than it should have. Many questions sent to Pelita and
Eerita Yudha newspapers, asked for this basic information. These letters 
came from many provinces all over Indonesia. Basic questions included:
-"Was the injectable contraceptive not dangerous for the users ?"• 
[Pelita, 9/1/1982: 4].
-"Was the injectable contraceptive available in dispensaries 
(commercial channels), and what is the name of this contraceptive?".
Was the injectable already approved by Islamic leaders ? ".
[Berita Yudha, 24/1/1982: 3]>
Besides that, up to the end of 1984, it seems to the author that 
this contraceptive was provided only for some "selected " women. It was 
not made available for every woman who needed it. This new contraceptive 
was provided free of charge for women who had failed with other 
available methods, women who had never used or refused to use other 
available methods and women who used condoms, other barrier methods and 
traditional methods.
In addition, BP is not considered as a long-term contraception by 
some decision makers in the Program, because it needs another injection 
every three month. It was hoped that BP users would be easily motivated 
to use an IUB later, (this contraceptive is considered as a 
"permanent" one, as it can be use for two to six years). Those policies 
were not written, but were expressed verbally by the Program leaders 
from the central office down to the provinces. An interview with Program 
leaders and newspapers confirmed the above impression, as can be seen 
below:
"We provided injectables for suplementary contraceptive 
purposes. This year (1985) BP will account for around 15 
percent of all contraceptive methods made available by the 
program".
"We selected the areas before we sent BP to the field. The 
"hard" areas (the areas where most women still refused to use 
any contraceptive), and condoms areas (the areas where most EP 
acceptors used condoms) were our priorities".
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These p o l i c i e s  a r e  a l s o  a p p a r e n t  i n  t h e  n e w s p a p e r s .  One f a m i ly  
p l a n n i n g  l e a d e r  from t h e  Implem en ting  u n i t  s a i d :
"Everyone s h o u ld  remember t h a t  t h e  i n j e c t a b l e  c o n t r a c e p t i v e  
was used as  t e m p o r a r y  c o n t r a c e p t i o n ,  and u s e r s  must  be d i r e c t e d  
to  use  a perm anen t  c o n t r a c e p t i v e  a s  soon a s  p o s s i b l e .  This  
method i s  c o s t l y  and n e e d s  a f o l l o w - u p  e v e r y  3 mon th s ,  t h a t  
means we have to  p r o v i d e  a l o t  o f  h e a l t h  p e r s o n n e l  t o  c o v e r  i t .  
I  was a f f r a i d  t h a t  i t  would be d i f f i c u l t  t o  meet  t h e  demand due 
to  t h e  l a c k  o f  h e a l t h  p e r s o n n e l " .  [Sua ra  Merdeka , 2 3 / 4 /1 9 8 5 :  
8].
This  s t a t e m e n t  p o i n t e d  o u t  t h a t  t h u s  p r o v i d e r s  recommended to  
use  on ly  IUDs which can be used  f o r  2 -5  y e a r s .  I t  i s  c o n s i d e r e d  
tobe  i n e x p e n s i v e  and does  n o t  need s e r v i c e s  e v e r y  few m onth s .
F u r th e r m o r e ,  t h e  s t a t e m e n t  below showed t h e  l i m i t e d  
d i s t r i b u t i o n  caused  by t h e  " s e l e c t e d  a r e a "  p o l i c i e s .
" F o u r t e e n  Ulama ( I s l a m i c  r e l i g i o u s  l e a d e r s )  from Aceh p r o v in c e  
made a v i s i t  t o  t h e  Head o f  t h e  Program a t  c e n t r a l  o f f i c e  i n  
J a k a r t a .  The main r e q u e s t  o f  t h e s e  Ulamas was, t h e  improvement 
o f  DP s t o c k s  i n  Aceh p r o v i n c e .  There  were many women who
r e f u s e d  to  t a k e  p a r t  i n  t h e  Program due to  t h e  l a c k  o f  t h i s  
method a t  t h e  s e r v i c e  p o i n t s " .  [ P e l i t a , 3 / 6 / 1 9 8 2 :  2 ] .
The f i e l d  work s t u d y  showed t h a t  t h e  above p o l i c i e s  ( a r e a  
p r i o r i t i e s ;  c o n s i d e r i n g  DP a s  a t em p o ra ry  c o n t r a c e p t i v e  and r e m o t i v a t e d
DP u s e r s  to  use  IUDs) d i d  n o t  work as  hoped .  As s e e n  i n  Tab le  4-9» women 
who c ou ld  n o t  u se  o t h e r  c o n t r a c e p t i v e s  b u t  used DP com pr i sed  on ly  6 p e r  
c e n t  o f  t h e  r e s p o n d e n t s .  A l so ,  a s  n o t e d  i n  s e c t i o n  4*3*2,  t h e  f i r s t  
s o u rc e  o f  i n f o r m a t i o n  a b o u t  DP f o r  more t h a n  h a l f  the  r e s p o n d e n t s  were 
h e a l t h  w o r k e r s ,  and n o t  f a m i l y  p l a n n i n g  w o r k e r s .  Th is  i n d i c a t e s  t h e  
weakness  o f  t h i s  s o u r c e .
Th is  method was f i r s t  used i n  I n d o n e s i a  by d o c t o r s  i n  t h e i r  
i n d e p e n d e n t  c l i n i c a l  s t u d i e s ,  t h e n  c o n t i n u e d  d u r i n g  t h e  t r i a l s  p r o j e c t  
p e r i o d .  These two p e r i o d s  were a lm o s t  t e n  y e a r s  l o n g ,  (1970 
1 9 7 9 /1980 ) ,  and h e a l t h  p e r s o n n e l ,  e s p e c i a l l y  d o c t o r s  a c cu m u la t e d  s t r o n g  
and r e l i a b l e  i n f o r m a t i o n  a b o u t  DP ( s ee  s e c t i o n  3*2)  However ,  n o t  many
m a r r i e d  women i n  t h e  r e p r o d u c t i v e  ages  (MWRA) were w e l l  in fo rm ed  abou t  
t h i s  method.  R u ra l  a g r a r i a n  women, who compr ised  most  I n d o n e s i a n  MWRA, 
were s t i l l  f a r  from g r a s p i n g  t h i s  method.  R u ra l  women a r e  m o s t ly  
u neduca ted  and u n f a m i l i a r  w i t h  m e d ic a l  p e r s o n n e l ,  and t h u s  t h e y  v e ry  
r a r e l y  a sk  f o r  t r e a t m e n t  from h e a l t h  c e n t r e .  In  a d d i t i o n ,  many r u r a l
peop le  l i v e  f a r  away from t h e  h e a l t h  c e n t r e .
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If DP was aimed at women who used condoms or other less efficient 
methods, as was hoped, the results of this objective were not 
satisfactory. Only 19 per cent previously used condoms and then changed 
to use DP, and the percentage changing from the IUD (which was 
considered a permanent contraceptive) to DP was also 19 per cent. Most 
women who chose DP in this study had previously used pills, 32 per cent 
(see Table 4-9* Altogether, more than half the respondents moved to DP 
from methods which were considered by the Program officers as " stable 
methods " IUDs and pill.
From the above facts it can be concluded that controversy 
surrounded the implementation of DP as a contraceptive, at least in the 
areas under study. On the one hand, DP was used by the Program to 
recruit women who still refused to join the Program. The candidates 
recruited with this contraceptive, were to be motivated to use other " 
stable " methods (especially IUDs) later. On the other hand, the IEC did 
not spreaded knowledge of DP to every women equally. These was probably 
becauseof the USFDA decision eight years earlier, which still influenced 
Indonesian Family Planning Officers.
4.4.1 The Pole of the Services
Most women in this study received their supplies of DP from FP
clinics. Three quarters obtained their first service, and 81 per cent
obtained their last service from clinics (see Table 4-7 and 4*4), but 
most were not satisfied with this kind of service, especially users who 
had to pay. Most women in Indonesia know that when provided by the 
Program, IUDs, pills, condoms, available in clinics can be obtained free 
of direct charge.
For DP users that rule did not apply. Three in every four
respondents receiving services from clinics had to pay, while other 
users received their DP totally free of charge (around 1/3 respondents). 
That is why many DP users dropped-out after several injections or 
changed to other methods (see Table 4-6).
"..... the FP acceptors among the grassroots level farmers,
asked the Program to give them DP totally free of charge", 
[Kedaulatan Rakyat, 3/4/1981: 4].
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"DP u s e r s  from one h e a l t h  c e n t e r  compla in ed  and pos tponed  
t h e i r  f o l l o w - u p  i n j e c t i o n s ,  b e c a u s e  t h e  c o s t  o f  DP s e r v i c e s  was
r a i s e d  from Rp500 t o  Rp2000" , [ P e l i t a , 8 / 3 / 1 9 8 4 :  5]«
The f i e l d  i n t e r v i e w s  r e c o r d e d  t h e  same phenomenon.
" I  had t o  pay f o r  my i n j e c t i o n  a f t e r  t h e  second f o l l o w - u p .  
The midwife  i n  my Puskesmas s a i d  t h a t  t h e r e  were no more s t o c k s  
of  DP from t h e  P rogram ".
" I  p o s tpone d  my f o l l o w - u p  i n j e c t i o n  s e v e r a l  t i m e s ,  u n t i l  I  saved  
enough money to  p u r c h a s e  i t .  I  used condoms f o r  s u p p le m e n ta r y  
c o n t r a c e p t i o n " .
" I  g o t  my DP when t h e  Puskesmas l au n c h e d  t h e  t r i a l  p r o j e c t .  
F ree  s e r v i c e  f i n i s h e d  a f t e r  e i g h t  i n j e c t i o n s  ( t h e  end o f  t h e  DP 
t r i a l  p r o j e c t ) .  I  p a id  Rp3000. each  f o r  t h e  l a s t  t h r e e  
i n j e c t i o n s .  When t h e  d a t e  came f o r  f o l l o w - u p  and I  d i d  n o t  have 
money, I  d id  n o t  go t o  t h e  Puskesmas .  To a v o id  p r e g n a n c y ,  I 
s l e p t  s e p a r a t e d  from my husband o r  we p r a c t i c e d  w i t h d r a w a l " .
About d e l a y i n g  t a k i n g  t h e  f o l l o w - u p  i n j e c t i o n  a d o c t o r  s a i d :
" I f  u s e r s  p o s tp o n e  t h e  d a t e  o f  t h e  f o l l o w - u p  i n j e c t i o n ,  they  
r u i n  t h e  c y c l e  o f  i n j e c t i o n s .  The d rug  may n o t  g i v e  p r o p e r  
p r o t e c t i o n .  The c y c l e  o f  i n j e c t i o n s  h a s  been  p lanned  s i n c e  t h e  
f i r s t  i n j e c t i o n " .
F u r th e r m o r e ,  Powell  and Seymour [1971:  3 7 ] ,  found i n  t h e i r  s t u d y  
t h a t  some u s e r s  who were 2 weeks l a t e  r e c e i v i n g  t h e i r  f i f t h  i n j e c t i o n ,  
c o n c e i v e d .  T h i s  d e m o n s t r a t e s  t h e  s h o r t  t im e  a f t e r  t h e  3 months o f  
p r o t e c t i o n  t h a t  o v u l a t i o n  may o c c u r .
In  a d d i t i o n ,  a n o t h e r  s t u d y  found t h e  same c a s e s ,  caused  by t h e  c o s t  
o f  the  d rug  i n  J a k a r t a ,  d u r i n g  t h e  Ora l  C o n t r a c e p t i v e  S tudy ,  t h e y  found 
c u r r e n t  use  o f  i n j e c t a b l e s  low e r  t h a n  o f  p i l l s .  They s u s p e c t e d  t h i s  was 
caused by t h e  Program l i m i t a t i o n  o f  t h e  number o f  i n j e c t i o n s  t h a t  
a c c e p t o r s  co u ld  have f r e e  o f  c h a r g e .  In  1980 i t  was 8 i n j e c t i o n s ,  and i n  
1983/1984,  on ly  4 f r e e  i n j e c t i o n s  from Program s o u r c e s .  They a l s o  
p o i n t e d  ou t  t h a t  a c c e p t o r s  c o u ld  d rop  ou t  o r  c o n t i n u e  on i n j e c t a b l e s  
t h ro u g h  p r i v a t e  s o u r c e s  ( i f  t h e y  have to  buy w i t h  t h e  same c o s t ,  t h e y  
p r e f e r e d  t o  go t o  t h e  p r i v a t e  s o u r c e s )  and t h e i r  c o n t i n u a t i o n  would no t  
show up i n  t h e  Program s e r v i c e  s t a t i s t i c s  [ L u b i s  and P r i h a r t o n o ,  1984: 
6],
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The above discussion explains why DP was slow to become popular, 
and the continuation rates were relatively low (see Section 3*4 the 
results of the Modular survey, compared to the same study in Thailand.) 
If the information (IEC), the policies, and the services for DP had been 
equal to those for pills, DP might have become the "method of choice 
very soon, because the advantages are greater and the popularity of 
injections are greater than that of pills, which are currently the 
method of choice.
4*5 Summary of the Field Work Study
The aim of this field work study was to assess the acceptability of 
Depo Provera to Indonesian women, especially in the areas under study. 
The number of respondents who completed the interview was very small 
compared to the population or the family planning acceptors in the areas 
under study. However, the results still can be used to gain a general 
impression of program operations.
As Malcolm Potts observed, when a new method (such as DP) is added 
to the program, there is some degree of substitution with other methods 
and some fresh users who were not satisfied with any of the options 
previously available [ Potts, 1978: 235 ]• Thus, DP users in this study 
compriced some fresh users (who never used any contraception before) and 
some who switched from IUDs, pills and condoms. It was therefore not 
fair for the Program to adopt a policy that DP be provided only for the 
women who refused to use other, methods previously available or who 
failed from those other methods. It should available for every woman 
who need it, free from direct charges (as are other contraceptives 
provided by the Program). DP would help the Program offer more choices 
to eligible couples, and gained more acceptors.
Family Planning is about choices; choice of when to bear children, 
choice of how many children to have, and choice of; what methods. It is 
the most intimate and in some ways important part of any couple's 
decision. Philosophically, method of contraceptives is a choice offered 
to couples who make thier own evaluation and then choce the method 
suitable for them. Based on these reasons, again, it is seems not fair 
for Indonesian providers to consider DP as a "temporary" contraceptive,
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and decide that the users should be remotivated to use other methods 
(•which were considered as "stable methods"). Eiside showing lack of
appreciation of the couple's/ women decision in chosing a contraceptive 
method, these policies lacked a sound basis. The issue of a lack of 
medical personnel was not completely true, because, if a women 
returnning for an injection has no complaints, her visit last only in 60 
to 90 seconds. This includes time for a short interview with a doctor or 
midwives, paper work, and the injection itself [Rinehart, 1975: K-12]. 
From this one may calculate how many users can be served in one day's 
work. Furthermore, the injection services can be operated on a once 
every-three-months schedule, as it is only a matter of planning and 
maintainning the service to meet the demand.
The results of this study showed that 60 per cent of respondents 
still wanted to have 25 months protection from pregnancy in addition to 
the time they have already had. While 44 per cent of respondents who had 
already had a 9th to 13th injection at time of interview, reported that
they wanted to continue 25 months more. This proved the highly 
acceptability and challenging prospect to the Program. It also proved, 
if properly managed, EP would easily become a "stable" method in the 
Program, as shown by Chiang Kay program (Thailand) and Gunung -Maria 
program (private services in Tomohon, Forth Sulawesi, Indonesia). In 
these two program EP was the most popular and the continuaty was on a
par with IUEs and Pills, [Baldwin, 1978: 304; Earten, 1984: 7]*
The acceptability of EP to respondents of this study was also 
apparent in the following findings.
1. Although the greatest obstacle was the cost of the drugs, and 
most respondents postponed thier follow-up injections for that reasons, 
still, they did not drop-out. They used other methods or did something 
to avoid pregnancy, during their period without EP. These respondents
would have another injections, when they had enough money to pay for the 
service.
This "irregularity habit" of follow-up injections, influenced the 
continuation rates figures of this method in the statistical report 
recorded by the Program. This was because users who did not have another 
injections more than ten days after the three months period, were 
reported as droped-outs. The old users who came back after several
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weeks, were reported as new users to the central office. This may be one 
of several factors caused the continuation rate of DP in the Program to
appear relatively low, far below that of pills.
2. This study found that more than half of the respondents had used
other methods some time in the past, and at the time of interview they 
used DP, more than three-quarters had used DP for one year and more. 
This probably indicates that the selection of this method by the 
women/couples was mostly through evaluation, comparison and 
consideration, and the decision was most likely a solid decision, not 
just "follow the leader".
3. The respondents also pointed out that they could tolerate the 
side effects they experienced. It appeared that they easily managed the 
bleeding problems (irregular, spotting and heavy bleeding), while most 
women were happy about the most common side effect, amenorrhoea. As 
Moslem women cannot perform their daily religious duty during menses 
they welcomed the assation of this monthly interuption. Also, 
respondents who suffered from or expose to anaemia beneffitted by 
avoiding loss of blood, while others beneffitted because their breast 
milk was not suppressed.
Injected medications have been popular in Indonesia for a long 
time. This popularity stems from the yaws campaigns in the 1950s. The 
nature of administration of DP may have an appeal, and is culturally 
acceptable to both educated and uneducated rural women, and Moslem women 
as well. If the motivation and information about this drugs spreaded out 
openly to the grassroot level, and the back-up services within the grasp 
of all women (the cost and the logistics), the results of this study 
suggest it would not be difficult to bring DP up to par with IUDs and 
pills in Indonesian Family Planning Program.
The interviews with weomen have convinced the outher that the 
providers have miss treated DP as a method of contraceptive in the 
Program. They provided DP only for selected women, which means they did 
not make use of DP as an attractive model of ideal contraception which 
could play a very important role in the family planning program. The 
difference in the costs for each woman and for each service point 
confused most users. Eventually they blamed the Program, considering 
that the Program did not treat them equally with the users of other
methods.
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CHAPTER 5
SUMMARY AND CONCLUSION
W o r l d w i d e  e v i d e n c e  i s  m o u n t i n g  t h a t  DP i s  a  s a t i s f a c t o r y  
c o n t r a c e p t i v e  w i t h  s e v e r a l  a d v a n t a g e s  a n d  some d i s a d v a n t a g e s  an d  i t s  
p r o b l e m s  a r e  now c o m p a r a b l e  t o  t h o s e  o f  o t h e r  m e t h o d s .  The  d i s c u s s i o n s  
i n  t h e  A s i a n  W o r k s h o p  on I n j e c t a b l e  C o n t r a c e p t i v e s  i n  1978  and  o f  t h e  
M u l t i n a t i o n a l  C o m p a r a t i v e  S t u d i e s  i n  15 c o u n t r i e s  u n d e r  WHO 
c o o r d i n a t i o n s  ( S p e c i a l  P r o g r a m  o f  R e s e a r c h  D e v e l o p m e n t  a n d  R e s e a r c h  
T r a i n i n g  i n  Human R e p r o d u c t i o n ,  T a s k  F o r c e  on  Long A c t i n g  A g e n t s  f o r  t h e  
R e g u l a t i o n  o f  F e r t i l i t y )  , i n d i c a t e d  t h a t  t h e  u s a g e  o f  DP a s  a 
c o n t r a c e p t i v e  i s  b e i n g  c a r e f u l l y  m o n i t o r e d ,  [ B e n a g i a n o  and  F r a s e r ,  1 9 8 1 :  
5 0 6 ] .  The r e s u l t s  o f  t h e  p r e s e n t  f i e l d  w o rk  r e f l e c t  t h o s e  o f  o t h e r
s t u d i e s  w h i c h  s u g g e s t e d  t h a t  f o r  m o s t  women,  d i s r u p t i o n  o f  t h e  m e n s t r u a l  
c y c l e ,  t h e  m a j o r  s i d e  e f f e c t ,  i s  n o t  a  h e a l t h  h a z a r d .  Women e v e r y w h e r e  
h a v e  shown t h e m s e l v e s  q u i t e  c a p a b l e  o f  c h o o s i n g  w h e t h e r  o r  n o t  t h e  
a d v a n t a g e s  o f  t h e  d r u g  c a n  o v e r c o m e  t h e  s u s p e c t e d  d i s a d v a n t a g e s .  I t  i s
u n l i k e l y  t h a t  a  s i n g l e  c o n t r a c e p t i v e  w h i c h  w i l l  s a f e l y ,  c o n v e n i e n t l y  and  
e f f e c t i v e l y  m e e t  e v e r y  b o d y ' s  c o n t r a c e p t i v e  n e e d s  w i l l  b e  f o u n d .  
C u r r e n t l y  a v a i l a b l e  c o n t r a c e p t i v e s  do n o t  m e e t  t h e  b i r t h  c o n t r o l  n e e d s  
o f  a l l  women.
T h e r e  a r e  r e a l  p r o b l e m s  w i t h  e a c h  o f  t h e  c o n t r a c e p t i v e s  t h a t  a r e  
c u r r e n t l y  a v a i l a b l e .  B e f o r e  t h e  P r o g r a m  a d o p t e d  DP i n  1 9 8 0 ,  
o p e r a t i o n a l y  t h e r e  w e r e  o n l y  t h r e e  m a i n  m e t h o d s  i n  t h e  P r o g r a m ;  IUDs,  
p i l l s ,  c o n d o m s .  Foam a n d  v a g i n a l  t a b l e t  w e r e  n o t  p o p u l a r .  E e s i d e s  b e i n g  
i n c o n v e n i e n t ,  s u p p l i e s  w e r e  v e r y  l i m i t e d .  S t e r i l i z a t i o n  was  l e s s  p o p u l a r  
b e c a u s e  o f  Moslem l e a d e r s ,  d i s a p p r o v a l  [ H u l l ,  e t  a l . ,  1 9 7 7 :  1 9 ] ,  a n d  up  
t o  now i s  s t i l l  on  c l i n i c a l  t r i a l s .  The t h r e e  m a i n  m e t h o d s  a v a i l a b l e  i n  
t h e  P r o g r a m ,  a l s o  w e r e  u n p o p u l a r  f o r  v a r i o u s  r e a s o n s .  The  m o d e r a t e  
c h o i c e  i s  t h e  p i l l  w h i c h  i s  e a s y  t o  o b t a i n  s u p p l i e s  a n d  s i m p l e  t o  u s e ,
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so i t  i s  n o t  s u r p r i s i n g  t h a t  t h e  p i l l  i s  t h e  method o f  c h o i c e  i n  t h e  
P rogram .
The p r e s e n t  s t u d y  found t h a t  t h e  d e c i s i o n  t o  a d o p t  TP i n  t h e  
Program was based  on t h e  c o n t r a c e p t i v e ' s  a t t r i b u t e s  and t h e  p roblems o f  
s e r v i c e  p r o v i s i o n  e n c o u n t e r e d  i n  t h e  f i e l d ,  t h a t  s t i l l  many women 
r e f u s e d  to  use  c o n t r a c e p t i v e  p r o v id e d  by t h e  Program. The e x p e r i e n c e  
from world wide use  c o n v in c e d  I n d o n e s i a n  Family  P l a n n i n g  d e c i s i o n  makers
t h a t  DP i s  more o r  l e s s  e q u a l  w i th  IUDs and p i l l s .
As an i n d e p e n d e n t  n a t i o n ,  I n d o n e s i a  sho u ld  make i t s  own d e c i s i o n
c o n c e r n i n g  c o n t r a c e p t i o n  w i t h o u t  f o l l o w i n g  o t h e r  c o u n t r i e s  o r  t h e  USFDA. 
DP as  a c o n t r a c e p t i v e  i s  c u l t u r a l l y  a c c e p t a b l e  to  most  women i n  
d e v e l o p i n g  c o u n t r i e s  and t o  I n d o n e s i a n  women a s  w e l l .  T h e r e f o r e ,  i t  i s  
c o r r e c t ,  t h a t  I n d o n e s i a  i n c l u d e d  DP i n  t h e  f a m i l y  p l a n n i n g  program,  
b e c a u s e  t h e  demand from t h e  women had r o s e  s i n c e  1973 [ E a r t e n ,  1976: 9]*
The f i n d i n g s  o f  t h i s  s t u d y  s u g g e s t  t h a t  I n d o n e s i a n  women were 
h i g h l y  t o l e r a n t  o f  t h e  s i d e  e f f e c t s ,  and used  i t  f o r  a c o n s i d e r a b l e  
t i m e .  However,  t h e  c o s t  o f  t h e  d r u g s ,  t h e  s e r v i c e ,  t h e  poor  i n f o r m a t i o n  
and m o t i v a t i o n  and l i m i t e d  l o g i s t i c s  p r e v e n t e d  i t  from r e a c h i n g  a l l  
women who needed  i t ,  ( s e e  d i s c u s s i o n  i n  s e c t i o n  4*4,  c h a p t e r  IV ) .  An 
e f f o r t  t o  r e a c h  poor  and u n e d u c a t e d  p e o p le  i n  r u r a l  a r e a s  was made by 
the  Program, b u t  t h e r e  were d i f f e r e n c e s  i n  t h e  a v a i l a b i l i t y  o f  
i n f o r m a t i o n  and s e r v i c e s  and d i f f e r e n c e s  i n  t h e  c o s t  be tween  p l a c e s ,  
even w i t h i n  t h e  P r o g r a m ' s  c l i n i c s .  The use  o f  c o n t r a c e p t i v e s  ( e s p e c i a l l y  
DP) , may have been i n f l u e n c e d  by a c c e s s  t o  i n f o r m a t i o n  and a v a i l a b l e  
s e r v i c e s  and t h e  c a p a c i t y  t o  b e a r  t h e  c o s t .  The p r o v i d e r s ,  i t  seems,  
c o n c e n t r a t e d  t h e  i n f o r m a t i o n  s e r v i c e s  on p i l l s  and IUDs r a t h e r  t h a n  DP.
The r e s u l t s  o f  t h e  f i e l d  work s t u d y  s u g g e s t  t h e  main o b s t a c l e  which 
made t h e  c o n t i n u a t i o n  r a t e  o f  DP r e l a t i v e l y  low,  even worse t h a n  p i l l s ,  
was t h e  c o s t  o f  DP a t  t h e  s e r v i c e  p o i n t s .  P e r h a p s  i f  t h e  Program cou ld  
make DP t o t a l l y  f r e e  i n  e v e ry  f a m i l y  p l a n n i n g  c l i n i c ,  and i f  t h e  
s u p p l i e s  o f  t h e  d rug  met demand, t h e  pe r f o r m a n c e  o f  DP i n  t h e  Program 
would show i t s  r e a l  p o t e n t i a l .  For  t h i s  t o  come a b o u t ,  many p o l i c i e s  and 
a c t i o n s  i n  t h e  Program s h o u ld  be a l t e r e d .  Fo r  example,  DP i s  aimed 
m a i n ly  a t  women who have r e f u s e d  to  use  o t h e r  c o n t r a c e p t i v e s  a v a i l a b l e  
i n  t h e  Program. The second  t a r g e t  f o r  DP were t h e  women who used  condoms 
o r  o t h e r  methods c o n s i d e r e d  by t h e  Program a s  i n e f f e c t i v e .  E e s u l t s  o f
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field study pointed out that more than half of respondents (70 %) used 
another methods before chosed DP, and 50% were ex pills and IUDs users. 
DP was available only for women who had completed their families or at 
least had two children. This policy no longer has any strong rational 
reasons, as it is based on an old theory that DP permanently impaired 
the fertility of users. Current data show, its reversibility is 
comparable to pills and IUDs (see section 2.7 )•
It was also considered that DP was a "temporary" contraception, and 
the users should be remotivated to use IUDs. This policies would also 
need to be reversed, as the old rationale no longer applies. The results 
of this study suggest that the effectiveness, the pregnancy rates, and 
the reversibility of this method is equal to IUDs; in some programs, 
even better. Results from field work also supported this. DP even became 
a preferred method for most Moslem women which to Indonesia is a benefit 
as 2/3 of MWRA of Indonesia are Moslem. It seems reasonable to give DP a 
chance to realize its potential to become a method of contraception used 
by women for a considerable time.
The special benefit of DP to the Program was that it made it 
possible to use Mobile Medical Teams on a 3 months schedule. This saves 
a lot of medical personnels and expenditure. Also, by 3 monthly 
schedules, it is possible to reach remote areas such as Kalimantan, 
Maluku and Irian Jaya, with less problems in following-up. This action 
could open a new era, and the Program could reach people in remote 
areas. The Program could also serve all Indonesians who live in any 
areas of the Indonesian islands. By increasing the use of DP, errors in 
monthly Service Statistical Reports could be reduced as they are usually 
caused by estimations of the Atage of pills and condoms.
With these improvements, perhaps, it would be easier for the 
Program to maintain the achievement levels. Properly managed DP can
accelerate the demand for modern contraceptives in Indonesia, and 
contribute to the goals of reducing fertility and improving the quality 
of life of the Indonesian people.
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APPENDIX A
THE OPPONENTS AND THE SUPPORTERS ARGUMENTS 
ABOUT DEPO PROVERA AS A CONTRACEPTIVE.
The Opponents Arguments ! The Supporters Arguments
1. Studies in beagle dogs have 
shown an increased incidence 
of mammary carcinoma 
associated with DP
a. The safety questions raised
by the animal data have 
not been resolved.
b. Accordingly, the FDA still 
views this drug as posing 
a substantial risk to 
potential users.
c. None of the approved 
contraceptives demonstrate 
these findings.
[FDA, 1978: 252]
Malignant tumours and other 
breast pathologies occured in 
conjunction with endometrial 
disease, even on low doses of 
DP. Some of the mammary
tumours in beagles were 
similar to those found in
humans. The drug also induced 
diabetes and hyperlycemia
[Minkin, 1980: 53].
1. The worldwide usage, trials 
and studies of DP injectable 
contraceptive totalled more 
than 6 million women years 
(at 1978). Experience had not 
suggested any increased risk 
of breast cancer in women 
using this drug.
[Upjohn, 1978: 253]*
Estrogen, which is used in 
most Oral contraceptives, 
has been associated with 
mammary cancer in mice and 
other tomurs and cancers in 
various species (rabbits, 
mice, guinea pigs, monkeys) 
but those contraceptives were 
approved [Upjohn, 1978: 254]»
The findings in beagle dogs 
were not relevant to women 
[Eriggs, 1977: 278; Potts, 
1978: 235]. With than 15 
years of experience there 
have been no known
fatalities related to DP 
administration in humans
[Eenagiano and Fraser, 1978:
504].
Studies in humans have not 
shown any increase in breast 
tumors or cancer [Kane,
1983: 74].
No data from adequate studies 
have shown any effect on 
the risk of neoplasia [WHO, 
cited in Maine, 1978: 343].
2. Since 1973-1974, when the 
FLA was willing to approve,
it has concluded that 
in the US, :
a. There was no definitive 
evidence of a significant
patient population needing 
the drug, and for any- 
existing population the 
risks outweighed the benefits
b. There was less evidence of
demand from physicians or 
patients for this drug.
c. Availability of many safe, 
effective alternative 
methods, has decreased the
need to used LP.
d. Eecause of these factors, 
the Upjohn Company would not 
be able to acquire enough 
patients to complete post­
marketing studies within
a reasonable time.
e. The FLA recognizes that 
benefit/risk considerations 
may be different in other 
nations.
[FLA, 1978: 266].
3* Physicians were likely to 
administer estrogens to 
control irregular bleeding 
induced by LP.
This would impose an added 
risk factor and would 
decrease the benefits of a 
contraceptive made only of 
a progestagen.
[FLA, 1978: 286]
2. U.S. physicians continue to 
declare that LP is the best 
contraceptive for certain 
patients.
Experience in patients does 
not support the view that LP 
is a potentially high risk 
method and other methods safe.
No method is completely safe.
Some groups of women needed 
LP as their contraceptive:
- Women who found an inject- 
tion easier than taking a 
pill daily, using coitus 
related methods or who have 
had difficulties with IULs.
- Women who have thromboebo-
lic complocation.
- Women who had estrogen- 
related complications.
- Retarded young girls.
In the 12 years old Chiang 
Mai program (June 1977)
69,316 women had received 
one or more injections 
(some up to 48 injections 
for a total groups 
experience of 146,508 
48 injections, for a total 
groups experience of 146,508 
women years, without a single 
known death [Cited in Upjohn, 
1978: 282].
3- The drug package insert
mentions the possibility that 
irregular bleeding or 
> amenorrhea might occur but 
does not suggest any means of 
treatment. On the other hand 
the package insert does not 
contra indicate this use of 
estrogens.
[Upjohn, 1978: 287]
Not every user needs 
estrogens. It can be replaced 
by good counselling.
[Me Laniel cited by Upjohn, 
1978: 287]
4* DP, like other progestogenic 
and estrogenic hormones, is 
associated with a risk of 
congenital malformations in 
infants exposed to the drug 
during pregnancy. Because 
of DP's long acting pharma­
cological activity, exposure 
of the embryo, with possibly
resultant increased risk, 
would be greater than with 
other compounds in the event
of pregnancy due to a drug 
failure. [FDA, 1978: 292]
5. The practical impossibility 
for the Upjohn Company to 
carry out the proposed pos ••
marketing study to determine 
the risk of breast and
cervical carcinoma.
[FDA, 1978: 298]
4* There was no definitive
evidence that DP causes birth 
defects in infants exposed to 
it during pregnancy, if the 
drug is given as recommended. 
[Upjohn, 1978: 292].
Existing studies so far, 
do not show any evidence of 
teragonic effect. [WHO cited 
in Maine, 1978: 345]
no invasive carcinoma and no 
other genital malignancy 
have been seen. [Powell and 
Seymore, 1971: 39]
It is extremely difficult to 
study because the pregnancy 
rate is only 0,5 percent. 
Pregnancies before the first 
injection were few when the 
injection was given in the 
first week in the menstrual 
cycle [Benagiano and Fraser, 
1981: 513; Siriwongse, et al., 
1982: 489]* Pregnancies 
after use rarely occur until 
hormone levels have dropped 
very low or are undetecable. 
[Eenagiano and Fraser, 1981:
513]
- Pregnancy with DP was uncommon 
uncommon, disorders infrequent 
frequent and any potential 
teragonic risk was very small. 
[WHO, 1982: 205]
5. The Upjohn company was able 
and willing to do an adequate 
postmarketing study. [Upjohn, 
1978: 298]
APPENDIX B
DEBATE ROSE IN 1980.
1. When the drug is injected,
the initial blood levels of 
DP are high enough to produce 
a "shock" to the hyphothalamus,
disrupting the menstrual cycle 
for three months or longer.
[Minkin, 1980: 50]
2. DP caused liver 
dysfunction.
[Minkin, 1980: 66-67]
3. The drug interferes with 
carbohydrate metabolism in 
women.
[Minkin, 1980: 59]
1. Evidence available so far 
demonstrated that DP did not 
cause any central shock:
- basal levels of
luiteinising hormone (LH) 
and follicle-stimulating 
hormone (FSH) 
were not suppressed to as 
severe a degree by DP as they 
were by Oral contraceptives
- The pituitary response to an 
injection of Luiteinizing 
Hormone- Releasing Hormone 
( LH RH ) is prompt and 
indistinguishable from 
normal control.
Several investigators have 
failed to demonstrate any 
effect on basal growth 
hormones released in normal 
women taking DP as a 
contraceptive. [Benagiano 
and Fraser, 1981: 508]
2,. A multi-center study carried 
out under the auspices of WHO 
did not find any significant 
change in liver. [Benagiano 
and Fraser, 1981: 509]
3- DP has an advantage over 
Oral pills on the basis that 
there were less alterations 
in carbohydrate and lipid 
metabolism. [Diana, et al., 
1985: 51-64]
4. DP i n h i b i t s  t h e  p r o d u c t i o n  
and a l t e r s  t h e  d i s t r i b u t i o n  
o f  a n t i b o d i e s .
[Minkin ,  1980: 58]
5* Some s t u d i e s  i n d i c a t e d  
t h a t  t h e  s u p p l y  o f  m i lk
was reduced  and co u ld  harm 
i n f a n t s  by i n t e r f e r r i n g  
w i th  immunoglobins  i n  t h e  
b r e a s t  m i l k .
[Mink in ,  1980: 61 -62]
6. DP u s e r s  w i l l  s u f f e r  
u t e r u s  a t r o p h i e s ,  s t o p  
o v u l a t i n g  and become
q f  p-pn 1  p
[Minkin ,  1980: 66]
4. The i m m u n o - e l e c t r o p h o r e t i c  
p a t t e r n  i n  b r e a s t  m i lk  and 
serum i s  n o t  m o d i f i e d  by DP. 
[B enag iano  and F r a s e r ,  1981:
511]
No a l t e r a t i o n  o f  the  
i m m u n o - e l e c t r o p h e r i c  p a t t e r n  
o f  m a t e r n a l  m i l k  d u r i n g  DP 
se  was d e t e c t e d .
J im e ne z ,  e t  a l . ,  1984: 530 ]
5. Long term f o l l o w  up o f  
c h i l d r e n  b r e a s t  f ed  by m o th e r s  
r e c e i v i n g  DP showed no i l l  
e f f e c t s  on t h e i r  g rowth  and 
deve lopm en t  and h e a l t h  s t a t u s  
t h a t  can be a s s o c i a t e d  w i th  
t h e  u se  o f  DP.
[ J i m e n e z ,  e t  a l . ,  1984: 
525-535]
6.  No c o r r e l a t i o n  be tween  th e  
r e t u r n  t o  o v a r i a n  f u n c t i o n  
and t h e  d u r a t i o n  o f  drug  
e x p o s u re  was found .
[ F l o r e s ,  e t  a l . ,  1985: 561-
366]
R e tu rn  o f  f e r t i l i t y  a f t e r  
d i s c o n t i n u a t i o n  h a s  i n d i ­
c a t e d  t h a t  t h e  mean t ime  
b e f o r e  c o n c e p t i o n  i s  5*5 
mon ths .  [ P a r d t h a i s o n g , 
e t  a l . ,  1984: 23]
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APPENDIX C
EARLY STUDIES OF INJECTABLES AS A CONTRACEPTIVE 
IN INDONESIA.
Year ! Name ! location ! No of !Type of!Duration! Findings !
! ! !samples!Drug ! ! !
1967 Sulaiman, 
Agoestina
Bandung 147 DP 12
months
- no signifi­
cant side- 
effect .
- DP is a long 
acting con­
traceptive .
1968 Agoestina Bandung 100 DP 36
months
- reversibili­
ty 80 % af­
ter 1 year.
1970 Sulaiman, 
Biben,
Bandung 1051 DP
and
87
months
- no method 
failure for
Rusmana. Norigest DP
- 2.3 method 
failure for 
Norigest.
- 100 % of DP 
users get 
amenorrhea
- most of No­
rigest us­
ers get 
bleeding.
1972 Agoestina Bandung 100 DP 36 - no lactation
months suppressure
- most users 
tolerated 
the side- 
effects.
27 - method fail-
months ure 0.12 per 
100 women year.
- as popular as IUD
- side effect: 
menstrual disturbances
1973 Barten Tomohon 1285 DP 
Minahasa
1973 Sabirin Surabaya 48 DP
1974
1974
1974
1975
1975
24 - 34*2 $ users
months get amenorr­
hea .
- 19-2 $ bleeding 
-17 $ spotting
- effectivity 100$
Pardoko Surabaya 105 DP 36 - no method
months failure
- Continuation 
rate, 55 $ (12mt) 
34$ (24 mt)
- side effects: 
menstrual disturbances
21 - no method
months failure.
- most users 
get amenorrhea
17 - Continuation
months rate 60 $
after 12 mth
- no affect on 
blood pressure
- no lactations 
suppressure.
-effective.
16 - no lactation
months suppressure.
- no method 
failure.
- continuation 
rate 80 $, 1 year.
12 - Continuation
months rate two time 
compared to pill
- side effects: 
Pill: bleeding,
weight gain 
Norigest; bleeding, 
spotting, amenorrhea.
Noeroel Klaten 100 DP 
Suherman
Syamsuri, Surabaya 100 Norigest 
E.Djuarsa,
Hariadi,a,
Sudoko,H,
Wayan Giri.
Lorens Jakarta 58 Norigest 
Rumanow,
Sutopo
Biran Jakarta 51 Norigest 
Affandi. 1155 Pills
Harun
Harahap.
APPENDIX D
STUDIES OF INJECTABLES AS A CONTRACEPTIVE IN 
INDONESIA CONDUCTED AFTER THE INJECTABLES SEMINAR OF 1976.
Year
1976
1977
1978
! Name [Location!No of! Type of!Duration! Findings
! ! !sampl! drug ! !
Simanjuntak,Medan 400 Norigest 24 Both of the
Sembiring, months drugs are safe
Hanafiah, Singapore 200 and and effective
Sinnathuray, for contra-
Sen,D.K Kuala-
Ratnam,S.S Lumpur
200 DP ceptive
90.5 % of the 
users got 
amenorrhea 
after 9 months
Pregnancy rate, 
DP, 0.24 
NET EN, 0.48 
per 100 women
Continuation 
rates, after 
24 months:
DP 466.2 %
NET EN 68.2 %
IPPA Bengkulu 204 DP 56 No method
Parepare 541 months failured
Manado
Banjar-
1149
well accepted
masin 500 needs more IEC
Jambi 500 in the society
Barten Tomohon 895 DP 18 Continuation
North months rates, after
Sulawesi 18 months:
69-5 %
1980 Barten
1982 Hermini, 
Budianto, 
Yudo.P,
Biran- 
Affandi.
1984 Agoestina 
Bhiwan-
diwala, 
Fieldblum, 
Mukawi,
Setiadi, 
Ridwan.
Tomohon 275
Worth
Sulawesi
Bali, 1466
East Java,
West Java,
East Wusa- 
Tenggara,
Worth 
Sulawesi, 
Jakarta
Bandung 755
DP 12
months
WET EW 18 
months
DP 24
months
Return of 
pregnancy is 
8.8 months 
after last 
injection.
Wo influence 
on body weight 
and blood 
pressure
33 % of users
experienced
amenorrhea
Failure rate 
0.17 per 100 
women years.
Had no signi­
ficant health 
impact
Low risk of
unintended
pregnancy
no sign of 
of endometrial 
cancer
no congenital 
malformation
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APPENDIX E
SEMINAR ON DEPO PROVERA
The first seminar was held in Jakarta on July 1976, organized by 
Bureau of Contraceptive services (NFPCB). This seminar was attended by 
medical researchers from Research and Medical Development Centers in 
Java, Bali and North Sulawesi provinces. It was sponsored by Shering and 
the Upjohn company in Jakarta. This first seminar recommended a pilot 
project or field trials offering injectables as contraceptives in at 
least one training hospital for every province in Java and Eali (the 
seminar asked Dr.J. Barten to continue her North Sulawesi study of Depo 
Provera in Tomohon ).
The second seminar was held in Jakarta on June 1978. The organizer 
and the participants were the same as for the first seminar, and it was 
funded jointly by Shering, the Upjohn company and NFPCB. This meeting 
aimed to evaluate the field trials which were done up to the fourth 
injection. The main recommendation of this seminar was to continue the 
field trials up to the eighth injection. It also noted that due to the 
lack of Norigest, the trials of this drug were postponed until it became 
available in Indonesia.
The Third seminar, held in Jakarta on November 1979, has organized 
by Bureau of medical services and fully funded by the NFPCB.
The participants were; all participants who attended the second 
seminar, the head of medical services section of NFPCB in Java, Bali and 
ten provinces Outer Islands I, and the implementing unit who served 
contraceptives to society (such as IPPA, Indonesia Churches Council, 
Armed Forces, Muhamadyah).
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The i m p o r t a n t  r ecommenda t ion  o f  t h i s  t h i r d  s e m in a r  were :
1. Accord in g  to  t h e  r e s u l t s  o f  c l i n i c a l  and f i e l d  t r i a l s ,  t h e y  
a g re e d  t o  use  Depo P r o v e r a  a s  a c o n t r a c e p t i v e s  i n  s e v e r a l  h o s p i t a l s  w i th  
s t r o n g  c o n t r o l s .
2. Spread  t h e  i n f o r m a t i o n  a b o u t  DP t h r o u g h  t h e  mass m ed ia .
3* F u r t h e r  s t u d y  i s  s t i l l  n e e d e d ,  e s p e c i a l l y  s e v e r a l  a s p e c t s  
c o n c e r n in g  s i d e  e f f e c t s  i n  long  run  u s e .
The F o u r th  s e m i n a r ,  h e l d  i n  Semarang on Mei 1980 was o r g a n i z e d  and 
funded by th e  I n d o n e s i a n  Churches  C ounc i l  (DGl) .
The p a r t i c i p a n t s  w ere ;  a l l  p a r t i c i p a n t s  who a t t e n d e d  t h e  t h i r d  
s e m i n a r ,  Edwin Me D a n i e l  o f  Me Cormic C h r i s t i a n  H o s p i t a l ,  Chiang Mai, 
T h a i l a n d ,  and Supporn Koetsawang o f  S i r i r a j  H o s p i t a l  Mahidol  U n i v e r s i t y ,  
Bangkok,  T h a i l a n d ,  and a l s o  F e l i x  R o s a r i o ,  P r o j e c t  D i r e c t o r  o f  Ne ighbors  
Family  P l a n n i n g  S e r v i c e s  C e n t e r ,  Zamboanga c i t y ,  P h i l i p p i n e s .
The s u g g e s t i o n s  t h i s  s e m i n a r  made to  t h e  NFPCB were a s  f o l l o w s :
1. Accept  Depo P r o v e r a  f o r  t h e  N a t i o n a l  Family  P l a n n in g  Program, so 
t h a t  t h e  methods c o u ld  be e n r i c h e d .
2. Give good c o u n s e l l i n g  t o  a c c e p t o r  c a n d i d a t e s  and o ld  a c c e p t o r s  
e s p e c i a l l y  c o n c e r n i n g  c y c l e  d i s t u r b a n c e s .
3* P r o v id e  good communica t ion  f a c i l i t i e s  t o  g i v e  g u i d a n c e  f o r  
a c c e p t o r s  i n  o r d e r  t o  g u a r a n t e e  r e g u l a r  r e - v i s i t s  and r e -  e x a m i n a t i o n s .
4« I n v e s t i g a t e  more c a r e f u l l y  t h e  r e l a t i o n s h i p  be tween  t h e  u se  o f  
DP and s i d e  e f f e c t s ,  e s p e c i a l l y  c a n c e r ,  i n  long  run  u s e .
5.  Make DP a v a i l a b l e  o n ly  f o r  t h e  women who a l r e a d y  have a t  l e a s t  
two c h i l d r e n  [NFPCB, 1980: 6 ] .
APPENDIX F
THE MAIN QUESTIONS USED IN THE INTERVIEW.
No! VARIABLE ! QUESTIONS
I !
!Major Types of Answers 
!Received.
1. Duration of 
use
How long have you used 
DP?
a. 1 - 3  injection
b. 4 - 8 injection
c. 9 - 12 injection
d. 13 and more injection
2. Source of 
information
From whom did you 
first hear about DP?
a. FP Workers
b. Health Workers
c. Village Head
d. Family/relatives
e. Others
3» Reasons for 
choosing DP
Why did you choose 
DP?
Why did you change 
to DP?
a. I like it/practical
b. I cannot use other 
methods
c. Follow the 
suggestion of others
d . Others
a. I failed with IUD
b. I failed with pills
c. I failed with condoms
4.Number of Did you use another
other methods method before using 
used DP?
a. DP was my first method
b. DP was my second "
c. DP was my third
What method dj.d you a.IUDs
use the first time? b.Pills
c. Condoms
d. Others
What was the last a.IUDs
method you used before b.Pills
using DP? c.Condoms
d.Others
5.Users Opinions According to your 
about DP experience, what are
your comments about 
DP?
a. more practical
b. free from fear 
and embarrassment
c. free from 
forgetting
d. others
6.The Services Where did you obtain a.FP clinic
(first and DP for the first time? b.Private doctor
last service) c. " midwife
d. Mobile Med.Team
Where did you obtain a.FP clinic
the last/follow up b.Private doctor
injection? c. " midwife
d. Mobile Med.Team
7.The Cost Did you pay? a .yes 
b.no
If yes, how much? a. PpO.O - PpO.O
b. RpO.O - Rp499
c. Rp500 - Rp999
d. Rp1000- Rp1999
e. Rp2000- Rp4999
f. Rp5C00 - +
(1 A$ = Rp860)
8. The follow­ Were you ever late in a.Never
up injection taking your follow-up b.Late 1 — 2 weeks
injection? c.Late 3— 4 weeks
If late in taking a.Use pills instead
your follow-up, what b.Use condoms instead
did you do? c. Avoid intercourse
d. Nothing
9-Nursing Did you nurse your a .Yes
mothers baby? b.No
How was your breast a.As usual
milk? b. Eetter
c. Do not know
10.Continuation How long will you use a.O--6 months
of use DP? b.7 -- 12 months
’ c. 13 —  18 months
d. 20 -- 24 months
- e.25 —  and more
11.Side effects What side effects did a.Amenorrhea
you suffer? b. Spotting
c. Heavy bleeding
d. Irregular bleeding
e. Headache
f. Increase of weight
g. Nervousness
h. Others
12.The purpose What is your objective a.Stop/prevent
of using in using DP? pregnancy
b. Space children
c. Family welfare
d. Do not know
